FIELD OF THE INVENTION

[0001 ] This invention relates to porous crystalline materials, their synthesis and their use.

BACKGROUND OF THE INVENTION

[0002] One known family of porous crystalline materials are zeolitic materials, which are based on the 3-dimensional. four-connected framework structure defined by corner- sharing [T0 ₄ ] tetrahedra, where T is any tetrahcdrally coordinated cation.

Among the know ^? n materials in this family are silicates that contain a three-dimensional microporous crystal framework structure of [S1O4] corner sharing tetrahcdral units, aluminosilicates that contain a three-dimensional microporous crystal framework structure of [S1O ₄ ] and [A10 ₄ ] corner sharing tetrahcdral units, aluminophosphatcs that contain a three-dimensional microporous crystal framework structure of [A10 ₄ ] and [PO ₄ ] corner sharing tetrahedral units, and silicoaluminophosphates f SAPOs), in which the framework structure is composed of [S1O ₄ ], [AIO ₄ ] and [P0 ₄ ] corner sharing tetrahedral units. Included in the zeolitic family of materials are over 200 di ferent porous framework types, many of which have great commercial value as catalysts and adsorbents.

[0003) Zeolitic imidazolate frameworks or ZIFs have properties similar to inorganic zeolitic materials. ZIFs are based on [M(IM) ₄ J tetrahcdral bonds in which IM is an imidazolate type linking moiety and M is a transition metal. These materials are generally referred to as zeolitic imidazolate frameworks or ZIFs since the angle formed by tmidazolates (IMs) when bridging transition metals is similar to the 145° angle of the Si-O-Si bond in zeolites. ZIF counterparts of a large number of known zeolitic structures have been produced. In addition, porous iramework types, hitherto unknown to zeolites, have also been produced. Discussion of this research can be found in, for example, the following publications from Yaghi and his co-workers: "Exceptional Chemical and Thermal Stability of Zcolitic Imidazolate Frameworks", Proceedings of the National Academy of Sciences of U.S.A., Vol . 1 03, 2006, pp. 10186-91 , "Zeolite A Imidazolate Frameworks", Mature Materials, Vol. 6, 2007, pp. 501 -6, "High- Throughput Synthesis of Zeolitic Imidazolate Frameworks and Application to C0 ₂ Capture", Science, Vol. 319, 2008. pp. 939-43, "Colossal Cages in Zeolitic Imidazolate Frameworks as Selective Carbon Dioxide Reservoirs ^" . Nature, Vol. 453, 2008, pp. 207- 12, "Control of Pore Size and Functionality in Isorcticular Zeolitic Imidazolate Frameworks and their Carbon Dioxide Selective Capture Properties", Journal of the American Chemical Society, Vol. 131 , 2009, pp. 3875-7, "A Combined Experimental- Computational Investigation of Carbon Dioxide Capture in a Series of lsoreticular Zeolitic Imidazolate Frameworks", Journal of the American Chemical Society, Vol. 132, 2010. pp. 1 1006-8, and "Synthesis, Structure, and Carbon Dioxide Capture Properties of Zeolitic Imidazolate Frameworks", Accounts of Chemical Research, Vol. 43, 2010, pp. 58-67.

J0004] Much of this work on ZIF structures is summarized in U.S. Patent

Application Publication No. 2007/0202038, the entire contents of which are incorporated herein by reference. In particular, the '038 publication discloses a zeolitic framework, comprising the general structure: M-L-M, wherein M comprises a transition metal and L is a linking moiety comprising a structure selected from the group consisting of I, II ill, or any combination thereof:

)

wherein A , A , A , A , A , A , and A can be either C or N, wherein R ⁵ -R ⁸ are present when A ¹ and A comprise C, wherein R ¹ , R ⁴ or R ⁹ comprise a non-sterically hindering group that does not interfere with M, wherein R ² , R ³ , R\ R ⁶ , R ⁷ , R ⁸ , R ¹⁰ , R ^{1 1} , and R ¹² are each individually an alkyl, halo-, cyano-, nitro-, wherein M ¹ , M ² , M ³ , M ⁴ , M ⁵ , and M ⁶ each comprise a transition metal, wherein when the linking moiety comprises structure 111, R ¹⁰ , R ⁿ , and R ^{13 '} are each individually electron withdrawing groups.

[0005] in a more recent work by Ni et al , the structure and synthesis of mixed- valence ZIFs are disclosed in U.S. Patent Application Publication No. 2010/0307336. Specifically, the authors disclose in the '336 publication a porous crystalline material having a tetrahcdral framework comprising a general structure, M' -IM-M ² , wherein M ¹ comprises a metal having a first valency, wherein M ^~ comprises a metal having a second valency different from said first valency, and wherein IM is imidazolate or a substituted imidazolate linking moiety. Such materials can sometimes be described as iso-structural to known ZIF materials.

[00061 ZIF materials may be conventionally prepared by dissolving sources of metal ions and sources of imidazolate or substituted imidazolate linkers in an appropriate solvent to form a reaction mixture and then maintaining this reaction mixture under conditions sufficient to form the crystalline ZIF materials as a precipitate. For example, in U.S. Patent Appl icaton Publication No. 2007/0202038, it is stated that ZIF materials may be prepared using solvothermal techniques. These techniques may involve combining a hydratcd metal salt (e.g. , nitrate) and an imidazole-type organic compound in an amide solvent, such as Λ', Λ ^' -diethylformamide (DEF). followed by heating (e.g. , to 85- 1 50°C) the resultant solutions for 48-96 hours to precipitate with a zeolitic framework. [0007| One problem with the precipitation or solvothermal method for forming ZIF materials is that it affords one little or no control over the framework type of the zeolitic material obtained. For example, as reported in the literature, when a ZIF is crystallized from a solution of zinc ions and 5-azabenzimidazolc molecules, the resulting ZIF material (i. e. , ZIF-22) tends to have the LTA framework type; see, for example, the aforementioned article ''Zeolite A Imidazolate Frameworks", Nature Materials, Vol. 6, 2007, pp. 501 -6 by Yaghi and his co-workers.

[0008] Another problem with the precipitation or solvothermal method for forming ZIF materials is that it may be difficult or impossible to incorporate a desired functional group on an imidazolate-type linker into a ZIF of the desired framework type. As noted above, conventional synthesis of ZIF-22 results in a LTA structure having a 5- azabcnzimidazolate linker. The 5-aza group on the linker has functionality as a Lewis base, so it could have affinity for a gas molecule with an electrophilic center, such as carbon dioxide. However, ZIF-22 is not exceptional among ZIF materials in terms of CC>2 adsorption; see Example 5 of the present application and see also the CC adsorption data, reported in the aforementioned Nature Materials 2007 article, for ZIF- 20, which is the purine counterpart of ZIF-22 (i. e. , having "aza" functional groups at both the 5- and 7-positions instead of only at the 5-position. In fact, neither ZIF-22 nor ZIF-20 was even mentioned by Yaghi and his co-workers when they reviewed the CO? adsorption performance of ZIFs in "Synthesis, Structure, and Carbon Dioxide Capture Properties of Zeolitic Imidazolate Framcw ^: orks", Accounts of Chemical Research, Vol. 43, 2010, pp. 58-67. Without being bound by theory, ZIF-22 's mediocre performance in CO2 adsorption is believed to be a result of the 5-azabenzimidazolate linkers within the structure not being close enough to each other, which in turn can be due to the presence of large cages in the framework type LTA (i. e. , small β cages separated by large a cages). Therefore, in order to enhance C0 ₂ adsorption, it would be extremely desirable to have a ZIF composition that has the 5-azabenzimidazolate linker and a reduction in or absence of large cages, e.g. , the framework type SOD (i. e. , only small β cages), which has not been produced by the conventional method despite intense study on this synthesis system.

[0009] Accordingly, it would be desirable to provide methods for preparing ZIF materials affording greater control over the resulting structure, for example, affording the possibility of incorporating desired functional groups into ZIF materials having a desired framework type.

SUMMARY OF THE INVENTION

[0010] There is provided herein a method for, inter alia, obtaining improved ZIF materials with desired combinations of linker and framework type.

[0011] According to one aspect, a method is provided for exchanging or replacing at least a portion of the organic linker content of a zeolitic imidazolate framework composition. The method comprises the steps of: (a) providing a first zeolitic imidazolate framework composition having a tetrahedral framework comprising a general structure, M '-HVT-M ² , wherein M ¹ and M ² comprise the same or different metal cations, and wherein IM ^a is an imidazolate or a substituted imidazolate linking moiety; (b) providing a liquid composition comprising IM ^b , wherein IM ^b is an imidazolate or a substituted imidazolate which is different from lM ^a ; and (c) contacting the first zeolitic imidazolate framework composition with the liquid composition under conditions sufficient to exchange at least a portion of IM ^4* with at least a portion of IM ^b and to produce a second zeolitic imidazolate framework composition, M'-INT-M ² , wherein IM ^L comprises or is IM ^b .

[0012] In many desired embodiments, the framework type of the second zeolitic imidazolate framework composition can be different from the framework type obtained when a zeolitic imidazolate framework composition is prepared by crystallizing a liquid reaction mixture comprising a solution of M V IS/1 ² and I ^b (also called the

''conventional" method herein). However, in some embodiments, the synthesis method of linker exchange may alternately include the framework type of the first zeolitic imidazolate framework composition being the same as the framework type of the second zeolitic imidazolate framework composition.

[001 ] The first zeolitic imidazolate framework composition may comprise less than 1 mole percent, for example, less than 0. 1 mole percent, for example, no detectable amount, of IM ^b , based on the total moles of IM ^a and IM in the first zeolitic imidazolate framework composition. Additionally or alternately, the liquid composition contacted with the first imidazolate framework composition may comprise less than 1 mole percent, for example, less than 0.1 mole percent, for example, no detectable amount, of IM ^a , based on the total moles of lM and IM ^b in the liquid composition. Further additionally or alternately, the second zeolitic imidazolate framework composition may comprise at least 10 mole percent, e.g. , at least 50 mole percent, at least 90 mole percent, at least 99 mole percent, or about 100 mole percent, of IM ^b , based on the total moles of IM ^a and IM ^h in the liquid composition.

[0014] Both of the first and second zeolitic imidazolate framework compositions may comprise, for example, at least one transition metal. The transition metal may comprise, for example, at least one of the following group of metals: Sc, Ti, V, Cr, Mn, Fe, Co, Νί, Cu, Zn, Y, Zr, Nb, Mo, Tc, Ru, Rh, Pd, Ag, Cd, Lu, Hf, Ta, W, Re, Os, lr, Pt, Au, Hg, Lr, Rf, Db, Sg, Bh, Hs, Mt, Ds, Rg, and Uub. In certain embodiments, both the first and second zeolitic imidazolate framework compositions may comprise at least one monovalent metal in combination with at least one trivalent metal, as described in U.S. Patent Publication No. 2010/0307336.

[0015] Both of the first and second zeolitic imidazolate framew rk compositions may have a framework type selected from the following group of framework types: ABW. ACO, AEI, AEL, AEN, AET. A FG, AFI, AFN, AFO, AFR, AFS, AFT. AFX, AFY, AHT, ANA, APC, APD, AST, ASV, ATN, ATO, ATS, ATT, ATV, AWO,

AWW, BCT, BEA, BEC, BI , BOG, BPH, BRE, CAG. CAN, CAS. CDO, CFI. CGF, CGS, CHA, CHI, CLO, CON, CRB, CZP, DAC, DDR, DFO, DFT, DIA, DOH, DON, EAB, EDI. EMT, EON, EPI, ERE ESV, ETR, EUO, EZT, FAR, FAU, FER, FRA. FRL, CIS, GIU, GME, GON. GOO, HEU, IFR, IHW, ISV. ITE, ΠΉ, ITW, IWR, IWV, IWW. JBW, KFI, LAU, LCS, LEV, LIO, LIT, LOS, LOV, LTA, LTL, LTN, MAR, MAZ, MET MEL, MEP, MER, MFI, MFS, MON, MOR, MOZ, MSE. MSO, MTF, MTN, MTT, MTW, MWW, NAB, NAT, NES, NON, NPO, NS1, OBW, OFF, OS1, OSO, OWE, PAR, PAU, PHI, PON, ΙΌΖ, RHO, RON. RRO, RSN. RTE, RTI I, RUT, RWR, RWY, SAO, SAS, SAT, SAV, SBE, SBS, SB Γ, SFE, SFF, SFG, SFH, SEN, SFO, SGT, SIV, SOD, SOS, SSY, STF, STL S I T, SZR, TER, THO, TON, TSC, TUN. UEI, UF1, UOZ, USI, UTL, VET, VIT, VNL VSV, WEI, WEN, YUG, ZNL and ZON. Particular examples of these framework types can include CRB, DFT, CAG, SOD, MER, RI IO, ANA, LTA, DIA. Z I, GME. LCS, FRL, G1S, POZ, and MOZ.

[0016] Additionally or alternately, both of the first and second zeolitic imidazolate framework compositions may be considered to be porous crystalline materials having a tetrahedral framework. The structure or basic structural unit of these frameworks may be described in terms of the following fomulae IV, V, VI, or any combination thereof:

In these formulae A ¹ , A ² , A ^" \ and A ⁴ can each independently be selected from C. N, P, and B, and each of A ⁵ , A ⁶ , and A ⁷ can be either C or N. R ^~ -R ⁸ can individually be present when their corresponding A' -A ⁴ comprises C. R ¹ , R ⁴ , and/or R ⁹ may advantageously comprise a non-sterically hindering group that docs not (substantially) interfere with the adjacent M ^! or M ² . R ² and R ³ , as well as R\ R ⁶ , R\ and/or R ⁸ , when present, may each individually be hydrogen, alky , halo, cyano. or nitro. M ¹ and M ² may comprise the same or different metal cation. R ¹⁰ -R ¹² can individually be present when their corresponding A ^s -A ⁷ comprises C, in which case one or more of R^-R ^1" being present can optionally but advantageously be electron withdrawing groups.

[0017] According to a particular embodiment, the first zeolitic imidazolate framework composition may comprise the structure of formula IV, and the second zeolitic imidazolate framework composition may comprise the structure of formula V.

[0018] Particular examples of possible framework structures or structural units for both the first and second zeolitic imidazolate framework compositions can include formulae VII. VIII, IX, X, XI, XII, XIII, XIV, XV. XVI, XVII, and XVIII, as follows:

(XVlll)

H ₃ C CH ₃

[0019J According to particular embodiments, the first zeolitic imidazolate framework composition may comprise the structure of formulae VII, VIII, IX, X, XI, and/or XII, e.g. , the structure of formula VIII, and the second zeolitic imidazolate framewxirk composition may comprise the structure of formulae XIIL XIV, XV, XVI, XVII, and/or XVTTI, e.g. , the structure of formulae XIII, XIV, XV, and/or XVI. or the structure of formula XV.

[00201 IM ^b may advantageously comprise a functionality lacking in IM' ¹ . In such a situation, such functionality may provide the second zeolitic imidazolate material with an affinity for adsorbing a gas. For example, the functionality in IM ^b , which is lacking in IM ^a , may be a Lewis base functionality, and the gas to be adsorbed may be a Lewis acid and/or a molecule with an electrophihc center. One non-limiting example of a Lewis base functionality is the 5-aza functionality in 5-azabenzimidazolc; and a non- limiting example of a gas being a Lewis acid and/or a molecule with an electrophihc center is carbon dioxide. Alternately, the new functionality provided by IM ^b may include a Lewis acid functionality (e.g. , where lM ^b contains B); and a non-limiting example of the gas to be adsorbed in that case may be a Lewis base, such as ammonia.

[0021] In a particular example of a method for replacing at least a portion of a zeolitic imidazolate framework composition, the first zeolitic imidazolate framework composition can comprise or be ZIF-8, which contains zinc and a 2-methylimidazolate linker. ZIF-8 can be contacted with a solution, for example, where the solvent comprises (is) A' ^" ,V-dimethylformamide (DMF), and where the solute comprises (is) benzimidazole (i. e. , the protonated form of the second linker composition,

benzimidazolate). The contact of the solution with ZIF-8 can advantageously produce a second zeolitic imidazolate framework composition, which in this case can comprise (be) ZIF-7 (which contains zinc and a benzimidazolate linker). [0022] In another example of a method for replacing at least a portion of a zeolitic imidazolate framework composition, the first zeolitic imidazole framework

composition can again comprise or be ZIF-8. ZIF-8 can be contacted with a solution, e.g. , where the solvent comprises (is) N, N-dimethylforrnamidc (DMF), and where the solute comprises (is) 5-azabenzimidazole (i. e. , the protonated form of the second linker composition. 5-azabenzimidazolate). The contact of the solution with ZIF-8 can advantageously produce a second zeolitic imidazolate framework composition containing zinc metal and 5-azabenzimidazolate linker, which is designated herein as EMM- 19. Both ZIF-8 and EMM-19 exhibit the sodalite (SOD) framework type, whereas known ZIFs having a 5-azabenzimidazolate linker typically only exhibit the LTA framework type.

|0023] An aspect of the invention involves the production of zeolitic imidazolate framework compositions having an enhanced adsorption capacity for carbon dioxide at relatively low partial pressures. For example, there is provided a zeolitic imidazolate framework composition with (a) the SOD framework type and/or (b) the empirical formula, Zn(5-azabenzamidazolate)2, wherein the zeolitic imidazolate framework composition is capable of adsorbing: (i) at least 0.30 mmol of C0 ₂ per gram of zeolitic imidazole framework composition at a temperature of ~28 C and a C0 ₂ partial pressure of -75 Torr; (ii) at least 0.35 mmol of C0 ₂ per gram of zeolitic imidazole framework composition at a temperature of ~28°C and a C0 ₂ partial pressure of -100 Torr; and/or (iii) at least 0.50 mmol of C0 ₂ per gram of zeolitic imidazole framework composition at a temperature of -28°C and a C0 ₂ partial pressure of -200 Torr. An example of a Z.I F material with such enhanced C0 ₂ sorption capacity at low partial pressure is EMM- 19.

[0024] EMM- 19 is believed to represent a new composition of matter.

Accordingly, there is also provided herein a composition of matter having the empirical formula, Zn(5-azabenzimidazolate) , wherein the composition is a zeolitic imidazolate framework structure exhibiting the SOD framework type.

[0025] EMM- 19 may be used in a method for adsorbing and/or separating a gas from a fluid stream. The gas to be adsorbed/separated may comprise one or more of hydrogen, nitrogen, oxygen, a noble gas, carbon monoxide, carbon dioxide, sulfur dioxide, sulfur trioxide, hydrogen sulfide, ammonia, a hydrocarbon, an amine, or some combination thereof.

BRIEF DESCRIPTION OF THE DRAWINGS

(0026 J Figure 1 shows liquid-state 125 MHz ^lj C NMR spectra for five materials prepared in Example 1.

[0027] Figure 2 shows relative intensity changes as a function of time for relevant portions of the spectra shown in Figure 1 .

[0028] Figure 3 is an overlay of the X-ray diffraction patterns of the ZIF-8 starting material (top), the solid product recovered in Example 1 (middle), and the calculated stick pattern for ZIF-7 (bottom) based on single-crystal data (Proc. Mat. Acad. Set., U.S.A., 2006 ( 103), 10186- 10191 , Yaghi et ai ).

[0029] Figure 4 is an overlay of the X-ray diffraction patterns of the as-synthesized EMM-19 product from Example 2 (top) and as-synthesized ZIF-7 (bottom).

[0030J Figure 5 shows solid-state magic-angle spinning 125 MHz ^lj C NMR peaks for activated ZIF-7 and activated EMM-19, as measured in Example 3.

[0031] Figure 6 is an overlay of the X-ray diffraction patterns of the as-synthesized ZIF-22 (top), acetonitrile-exchanged ZIF-22 (middle), and activated ZIF-22 (bottom) prepared in Example 4, and the calculated stick pattern for ZIF-22 based on single- crystal data (Nat. Mater., 2007 (6), 501 -596, Yaghi et !.).

[0032] Figure 7 shows C0 ₂ adsorption/desorption isotherms for ZIF-7, ZIF-22, and two different experiments for EMM- 19, as well as N2 adsorption/desorption isotherms for ZIF-7 and EMM- 19.

[0033] Figure 8 is an overlay of the X-ray diffraction patterns of the ZIF-8 starting material (top), the product of Example 6 (middle), and the calculated stick pattern for ZIF-23 (bottom) based on single-crystal data (Mat. Mater., 2007 (6), 501 -596, Yaghi et ai ).

[0034] Figure 9 is an overlay of the X-ray diffraction patterns of the as-synthesized EMM- 19 of Example 2 (top), the product of Example 7 (middle), and the calculated stick pattern for ZIF-8 (bottom) based on single-crystal data {Proc. Nat. Acad. ScL, U.S.A., 2006 ( 103), 101 86- 101 91 , Yaghi et a/. ). [0035] Figure 10 is an overlay of the X-ray diffraction patterns of the product of Example 8 (top) and the calculated stick pattern for ZIF-8 (bottom) based on single- crystal data {Proc. Nat. Acad. Set, U.S.A., 2006 ( 103), 10186-10191 , Yaghi et al).

[0036] Figure 1 1 is an overlay of the X-ray diffraction patterns of the product of Example 9 (top) and the calculated stick pattern for ZIF-8 (bottom) based on single- crystal data (Proc. Nat. Acad. Sc , U.S.A., 2006 ( 103), 10186- 10191 , Yaghi et al. ).

[0037] Figure 12 is an overlay of the X-ray diffraction patterns of the product of Example 10 (top) and the calculated stick pattern for ZlF-7 (bottom) based on single- crystal data (Proc. Nat. Acad. Sc U.S.A., 2006 ( 103). 10186- 10191 , Yaghi er a/. ).

[0038] Figure 1 3 is an overlay of the solid-state ^lj C NMR spectra of the activated product of Example 10 (top) and activated ZlF-7 (bottom).

[0039] Figure 14 is an overlay of the X-ray diffraction patterns of the product of Example 1 1 (top) and the calculated stick pattern for ZIF-23 (bottom) based on single- crystal data (Nat. Mater., 2007 (6), 501 -596, Yaghi et al. ).

[0040| Figure 15 shows the results of indexing the X-ray diffraction pattern of the product of Example 1 1 using Materials Data JADE 9 software.

[0041] Figure 16 is an overlay of the X-ray diffraction patterns of the product of Reaction 1 of Example 12 (top) and the calculated stick pattern for ZIF-8 (bottom) based on single-crystal data (Proc. Nat. Acad. Sci., U.S.A., 2006 (103), 101 86- 10191 , Yaghi et al ).

[0042] Figure 17 is an overlay of the X-ray diffraction patterns of the product of Reaction 2 o Example 12 (top) and the calculated stick pattern for ZIF-23 (bottom) based on single-crystal data (Nat. Mater., 2007 (6), 501 -596, Yaghi et al ).

[0043] Figure 18 is an overlay of the X-ray diffraction patterns of the product of Example 1 1 (top) and the product of Reaction 3 of Example 12 (bottom).

[0044] Figure 1 9 is an overlay of the X-ray diffraction patterns of the as- synthesized E M- 19 of Example 2 (top), the product of Example 1 3 (middle), and the calculated stick pattern for zincite, ZnO (bottom).

[0045] Figure 20 is an overlay of the X-ray diffraction patterns of the as- synthesized ZIF-22 of Example 4 (top), the product of Example 14 (middle), and the as-synthesized EMM- 19 of Example 2 (bottom). DETAILED DESCRIPTION OF THE EMBODIMENTS

[0046J Disclosed herein is a new method for making porous crystalline materials, which are known in the art as zeolitic imidazolatc framework (Z1F) compositions. These Z1F materials may be described as having a tctrahedral framework comprising a general structure, M -1Μ-ΙνΓ, wherein M and M ^~ comprises the same or different metal, and wherein IM is an imidazolatc or a substituted imidazolate linking moiety. Though the term ''imidazolate" is used to describe IM, IM ^a , and IM ^b herein, it is noted that, at various stages in the methods according to the invention, the relevant

IM/IM ^: '/lM ^b may be an imidazole (neutral charge) at particular times in the reaction sequence(s); nevertheless, the fact that these components are described using the term "imidazolate" is merely for convenience and uniformity and should be understood to encompass both situations where they are holding/dclocalizing a charge and where they are neutral. In the method described herein, at least a portion of linking moiety (IM) in an existing ZIF material can be replaced or exchanged with another linking moiety by an exchange process. Also disclosed herein is a new material designated herein as EMM-19, and a method of using EMM- 19 to adsorb and/or separate gases, such as carbon dioxide.

[0047J All publications specifically referred to herein with respect to their relevant teachings concerning aspects of the invention(s) disclosed herein are hereby incorporated by reference in their entirety, as well as with specificity to the element(s) for which they were cited herein.

A. Introduction

[0048] Typical synthetic routes for ZIF materials disclosed in the literature are summarized below ^r in Scheme 1 , wherein M is a transition metal, typically in the form of a divalent cation, such as Zn ^{2 l} \ Co ² \ Fe ²⁺ , present in a metal salt starting material that is typically soluble in the synthesis solvent, wherein I is imidazolatc or a substituted imidazolatc linker, wherein H-IM is the corresponding neutral molecule of IM, i. e. , the protonated form ofTM. wherein M and M ^" arc two metals of di ferent valency, wherein M ¹ is typically a monovalent cation, such as Li , Cu ⁺ , Ag , present in a metal salt starting material that is typically soluble in the synthesis solvent, and wherein M ² is typically a trivalent metal, such as B ^J , A1 ^J+ , Ga ^J present in an anionic mononuclear complex tctrakis( l -imidazolyl)metallate with an overall - 1 charge. These synthetic routes are referred to herein as "the conventional method".

M ^2T + 2 H-IM ► M(IM) ₂ + 2 Ι-

ZIF

(M ) ⁺ + [(M ² )(IM) ₄ ]- ' Μ ² (ΙΜ)

ZIF

Scheme I

[0049| An alternate route of ZIF synthesis is described herein. This alternate route is based on exchanging the IM linkers in an existing ZIF material, as shown below in Scheme 2, wherein ZIF ^a is a starting material and ZIF ^b is a product, wherein M is typically a divalent transition metal, and wherein M ¹ and M ² are typically a monovalent and a trivalent metal, respectively. These alternate synthetic routes are referred to herein as "the exchange method".

M(IM ^a ) ₂ + 2 H-IM ^b ► M(I ^B ) ₂ + 2 H- IM ^A

ZIF Z!F ^b

M ' M ² (1M ^L1 ) ₄ + 4 H-IM ^B M ^! M ² (lM ^b ) ₄ + 4 ! l-I ^a

ZIF ^a ZiF ^b

Scheme 2

It should be understood that the H-IM ^b as shown in Scheme 2 above may be replaced, in whole or in part, by other sources of IM ^b , such as salts of IM ^h .

[0050] By employing an existing ZIF as a (solid) starting material, the exchange method can potentially overcome some of the intrinsic limitations of the conventional method for ZIF synthesis. For example, in the conventional method, the introduction of functional group(s) into an IM linker could lead to interactions between these moieties and could therefore cause the formation of specific oligomeric structures in the reaction mixture, which in turn would limit the framework types of ZIF product. However, such a limitation could be circumvented by exchanging such a functionalized linker into a prc-formed ZIF with a desired framework type. Additionally or alternately, in a conventional synthesis, the use of a functionalized 1M linker with substituent(s) participating in the coordination to metal ions could disrupt the coordination pattern needed for the formation of ZIF frameworks, which could thus lead to non-porous framework structures or even discrete molecular complexes. However, without being bound by theory, the interference of coordinating functional groups would be expected to be greatly reduced when such a functionalized linker is exchanged into a pre-formed ZIF structure. Further additionally or alternately, the deprotonation of H-IM, which may be a key factor controlling the kinetics and thermodynamics of ZIF formation, can be conveniently tuned in the exchange method by judicious choice of IM linker in the ZIF starting material.

[0051] It is worth noting that works on linker exchange in metal-organic frameworks (MOFs) have appeared in the scientific literature. Noticeably, Cohen et al. and Choe et al. have respectively reported the exchange of dicarboxylate- and bipyridine-type organic linkers in MOFs. See "Postsynthetic Ligand Exchange as a Route to Functionalization of 'Inert' Metal-Organic Frameworks ^" , Chemical Science, Vol. 3, 2012. pp. 126-30, and "Stepwise Synthesis of Metal-Organic Frameworks: Replacement of Structural Organic Linkers", Journal of the American Chemical Society, Vol. 1 33, 201 1 , pp. 9984-7. What is common in these works is the fact that they deal with relatively weak mcta!-1 inker interactions and/or very open framework structures. However, ZIFs are a unique type of substrate for linker exchange for two reasons: (a) the metal-imidazoiate interaction, M-IM-M, is typically strong, evidenced by the exceptional chemical and thermal stability of ZI Fs; and (b) the framework structures of ZIFs can often feature large cages connected through very small windows, which can tend to complicate the transport of reactants, especially bulky functionalized H-IM molecules. These two points have been established in the pioneering works by Yaghi and co-workers. See, for example, "Exceptional Chemical and Thermal Stability of Zeolitic Imidazolate Frameworks ^" , Proceedings of the National Academy of

Sciences of U. S.A ., Vol. 103, 2006, pp. 1 01 86-91 ; "Zeolite A imidazolate

Frameworks ', Nature Materials, Vol. 6, 2007, pp. 501 -6; and "Colossal Cages in Zeolitic Imidazolate Frameworks as Selective Carbon Dioxide Reservoirs ^" , Nature, Vol. 453, 2008, pp. 207- 12.

[0052] One specific example of the intrinsic limitations of the conventional method for ZIF synthesis can be found in the aforementioned "Zeolite A Imidazolate

Frameworks ^' ", Nature Materials, Vol. 6, 2007, pp. 501 -6, by Yaghi et at. This article reports a systematic study on three conventional ZIF syntheses using purine, 5- azabcnzimidazole, and 4-azabenzimidazole as organic linker, respectively (Scheme 3). After exploring a wide synthesis space, including linker/metal molar ratio (from 5 to 10), meta! concentration (from 0.05 to 0.2 mol/L), metal source (zinc nitrate and cobalt nitrate), crystallization temperature (from 65°C to 150°C), crystallization time (from 1 to 3 days), and addition of base (2 mol/L dimethylamine solution in ethanol), the authors observed that the system employing 4-azabenzimidazole linkers always yielded a non-porous ZIF with the framework type DIA (short for diamond), whereas the ones employing purine and 5-azabenzimidazole linkers always produced porous ZIF materials with the framework type LTA (short for Linde type A). The result was corroborated in a recent comprehensive review article by Yaghi et al. ; see Table 1 in "Synthesis, Structure, and Carbon Dioxide Capture Properties of Zeolitic Imidazolate Frameworks", Accounts of Chemical Research, Vol. 43, 2010, pp. 58-67. In the Nature Materials 2007 article, the authors attributed the finding, based on crystallographic data, to favorable intcrmolecular interactions resulting from the polarity of C-N bond at the 5- and 6- positions in purine and 5-azabenzimidazole (Scheme 4) and the lack thereof in 4-azabenzimidazole. Such attractive interactions w ^r cre theorized to stabilize double 4-ring (D4R), a crucial building unit for the framework type LTA.

Purine 5-Azabenzimidazole 4-Azabenzimidazo!e

Scheme 3

Dimeric Unit of Purinate Dimcric Unit of 5-Azabenzimidazolate

Scheme 4

[0053J As shown herein, by using the exchange method, it can be possible to circumvent the formation of D4R units and use 5-azabenzimidazole to synthesize a new ZIF material with a framework type different from that obtained by the conventional method (a "non-equilibrium" framework), i. e. , the framework type SOD (short for sodalite) instead of LTA, which is a framework type wherein β-cages are connected by directly sharing 4-rings rather than through D4R units. Specifically, one example of this non-equilibrium framework type can be achieved by exchanging 5- azabenzimidazole into a well-known, commercially-available ZIF-8 material, a Zn(2- methyiimidazolate)2 with the framework type SOD. The new composition disclosed herein, i. e. , a Zn(5-azabenzimidazolate)2 with the non-equilibrium framework type SOD, is referred to herein as EMM- 19.

[0054] EMM-1 has been found to exhibit desirable gas adsorption properties. The uses of ZIFs for gas storage and separation have been documented in a PCT Publication by Yaghi and co-workers (WO 2008/140788, entitled 'Adsorptive Gas Separation of Multi-Component Gases' ^" ) and a series of publications by Reyes, Ni, and co-workers (U.S. Patent Application Publication Nos. 2009/021 1440 entitled "Separation of Hydrogen from Hydrocarbons Utilizing Zeolitic Imidazolate Framework Materials ^"7 ; 2009/021 1441 entitled "Separation of Carbon Dioxide from Methane Utilizing Zeolitic Imidazolate Framework Materials"; 2009/0214407 entitled ' ^' Separation of Carbon Dioxide from Nitrogen Utilizing Zeolitic Imidazolate Framework Materials ^" ; and 2009/0216059 entitled "Separation of Methane from Higher Carbon Number

Hydrocarbons Utilizing Zeolitic Imidazolate Framework Materials"). The most striking example disclosed in the works by Reyes, Ni, and co-workers can be seen in the room-temperature C0 ₂ adsorption isotherm of ZIF-7, a Zn(benzimidazolate)2 with the framework type SOD. The isotherm has a hysteretic shape and features a sharp rise in the adsorption branch starting at a low C0 ₂ partial pressure of 60 kPa (0.6 atm), which is indicative of a structural transition induced by favorable framework-C02 interactions and makes ZIF-7 a promising material for C0 ₂ separation. We have now found that, by incorporating a basic heteroatom such as nitrogen into the linker of ZIF- 7, e.g. , by exchanging benzimidazolate with 5-azabenzimidazolate to produce EMM- 19, the framework-C0 ₂ interactions can be enhanced, and the threshold partial pressure for favorable C0 ₂ adsorption can be further reduced.

B. The Linker Exchange Method

[0055] In a step of the exchange method described herein, a first zeolitic imidazolate framework composition can be provided or selected. The first zeolitic imidazolate framework composition (ZIF ¹ ) can have a first organic linker composition (IM ^:1 ). Unreacted species or impurities can preferably be removed from the as- synthesized form of ZIF ¹ prior to exchange with a second organic linker composition (IM ^b ). These unreacted species or impurities may be removed by appropriate techniques, e.g. , involving washing and drying. For example, the as-synthesized form of ZIF ¹ may be washed with a suitable solvent, such as DMF, followed by solvent exchange with ethanol, acetonitrile, or the like, decanting solvent and drying, for example, under vacuum at ~250°C. A first zeolitic imidazolate framework composition sufficiently (substantially) free of unreacted species or impurities may be purchased from commercial vendors.

[0056| In another step of the method, a liquid composition comprising a second organic linker composition (IM ^b ) can be provided. The second organic linker composition may be present in a liquid composition, for example, in the form of the protonated form of the imidazolate type linker composition and/or in the form of a salt of the imidazolate type linker composition. This protonated form of the imidazolate type linker composition is referred to herein as H-IM ^b . The second organic linker composition (IM ) can be different from the first organic linker composition (IM ^d ) in many embodiments. IM ^b may advantageously comprise a functionality lacking in !M'\

[0057] The liquid composition may comprise a solution of the second organic linker composition (IM ^b ) in a solvent. The solvent may be a polar organic solvent, such as N,N-dimethylformamide (DMF), Ν,Ν-diethylformamide (DEF), N,N- dimethylacetamide (DMAc), 1 ,3-dimethylpropyleneurea (DMPU), a sulfoxide {e.g. , dimethylsulfoxide or DMSO), a phosphoramide (e.g. , hexamethylphosphoramidc), acetonitrile (MeCN), triethylamine (TEA), or a combination thereof. Alternatively, though not strictly organic, aqueous solvents such as aqueous ammonia and ethanol mixtures, can be used as solvents for the linker composition s).

[0058] Though polar organic compounds such as Ν,Ν-dimethylformamide (DMF) are suggested as solvents herein, it should be understood that a solvent (or solvent system) useful in the methods according to the invention and/or useful in making products according to the invention should at least be able to solvate and/or solubilize the reactants to the extent necessary to allow reaction to occur at a reasonable rate (or over a reasonable reaction time). They can also typically be present in a substantially liquid phase at operating/reaction conditions (and optionally but preferably also at STP). Additionally, in the case of synthesis of certain ZIFs, the solvent system may need to include a Bronsted or Lewis base (hydrogen acceptor) component, in order for the reaction to proceed (for instance in, but not limited to, cases where one component of the solvent is not sufficiently basic). Whether that Bronsted or Lewis base component comprises a portion of the single solvent molecule itself or includes a separate component having hydrogen acceptor functionality is not necessarily critical. It should further be understood that these aspects of the solvent (solvent system) may be equally applicable to "conventional" (solvothermal, etc.) syntheses as well as to the linker exchange synthesis methods detailed herein, as the aforementioned aspects can advantageously relate generally to Z1F and/or MOF synthesis reactions.

[0059] In certain embodiments, solvents (and/or solvent systems) particularly useful in the invention can additionally or alternately exhibit a relatively high vapor pressure and/or a relatively low boiling point. For instance, in some such

embodiments, a relatively high vapor pressure can represent at least 2.5 kPa at about 20°C, for example at least about 3.0 kPa at about 20°C, at least about 3.5 kPa at about 20°C, at least about 4.0 kPa at about 20°C, at least about 4.5 kPa at about 20°C, at least about 5.0 kPa at about 20°C, at least about 5.5 kPa at about 20°C, at least about 6.0 kPa at about 20°C, at least about 6.5 kPa at about 20°C, at least about 7.0 kPa at about 20°C, at least about 7.5 kPa at about 20°C, at least about 8.0 kPa at about 20°C, at least about 8.5 kPa at about 20°C, at least about 9.0 kPa at about 20°C, or at least about 9.5 kPa at about 20°C. Optionally, if an upper bound on vapor pressure is needed and/or desired, the relatively high vapor pressure can be about 30 kPa or less at about 20°C, e.g. , about 25 kPa or less at about 20°C, about 20 kPa or less at about 20°C, about 15 kPa or less at about 20°C, or about 10 kPa or less at about 20°C. Additionally or alternately, in some such embodiments, a relatively low boiling point can represent 99°C or less, e.g. , about 98°C or less, about 96°C or less, about 95°C or less, about 93 °C or less, about 91 °C or less, about 90°C or less, about 88°C or less, about 86°C or less, about 85°C or less, about 83°C or less, about 81 °C or less, or about 80°C or less. Optionally, if a lower bound on boiling point is needed and/or desired (preferably, the solvent can have a boiling point above ambient temperature, so as to be in a liquid phase), the relatively low boiling point can be at least about 25°C, e.g. , at least about 30°C, at least about 35°C, at least about 40°C, at least about 45°C, at least about 50°C, at least about 55°C, at least about 60°C, at least about 65°C, at least about 70°C, at least about 75°C, or at least about 80°C. One such non-limiting example of a solvent system having both a relatively low boiling point and a relatively high vapor pressure includes a mixture of acetonitrile and triethylamine.

[0060] In another step of the method, the first zeolitic imidazolate framework composition (ZIF ^! ) can be contacted with the liquid composition comprising IM ^b . This contact may take place by combining (1 ) the first ZIF ¹ , (2) the solvent, and (3) a source οΠΜ\ such as I I- IM ^b , in any order. For example, ZIF ¹ and H-IM ^b may first be combined, and the solvent may be added to this combination, accomplishing the simultaneous formation of a liquid composition comprising H-IM ^b and contact of this composition with ZIF ¹ . In a convenient embodiment, the source of IM ^b can first be dissolved in the solvent, and either the resulting solution can be added to ZIF' or ZI can be added to the solution.

[0061 ] The molar ratio of the first organic linker (IM ^a ) in the first ZIF (ZIF ¹ ) to IM ^b in the contacted or combined mixture of ZIF ¹ with the liquid mixture comprising IM ^b may be from 0.1 to 20, e.g. , from 0.1 to 15, from 0.1 to 10, from 0.1 to 7, from 0.1 to 5, from 0.1 to 3, from 0.1 to 2, from 0.1 to 1.5, from 0.2 to 20, from 0.2 to 15, from 0.2 to 10, from 0.2 to 7, from 0.2 to 5, from 0.2 to 3. from 0.2 to 2, from 0.2 to 1.5, from 0.3 to 20, from 0.3 to 15, from 0.3 to 10, from 0.3 to 7, from 0.3 to 5, from 0.3 to 3, from 0.3 to 2, from 0.3 to 1 .5, from 0.5 to 20, from 0.5 to 15, from 0.5 to 10, from 0.5 to 7, from 0.5 to 5, from 0.5 to 3, from 0.5 to 2, from 0.5 to 1 .5, from 0.8 to 20, from 0.8 to 15, from 0.8 to 10, from 0.8 to 7, from 0.8 to 5, from 0.8 to 3, from 0.8 to 2, from 0.8 to 1.5, from 1 to 20, from 1 to 15, from 1 to 1 0, from 1 to 7, from 1 to 5, from 1 to 3, from 1 to 2, from 1 to 1 .5, from 1.5 to 20, from 1 .5 to 15, from 1.5 to 10, from 1 .5 to 7, from 1 .5 to 5, from 1 .5 to 3, from 1 .5 to 2, from 2 to 20, from 2 to 15, from 2 to 10, from 2 to 7, from 2 to 5, or from 2 to 3. When complete or substantially (e.g.. at least 90%) complete exchange of IM ^a with lM ^b is desired, the molar ratio of IM ^h to H-IM may advantageously be at least 1 , e.g. , at least 1.2, at least 1.5, or at least 2.

[0062 ] The combined mixture of ZIF ¹ with the liquid composition comprising IM ^b can be maintained under conditions sufficient to achieve at least partial exchange of lM ^a with I ^b , thereby effectively converting ZIF ¹ at least partially into ZIF ^{^} . The contact may take place for a sufficient time to achieve at least partial exchange, e.g. , from at least 1 hour to as much as 10 days, from 1 hour to 7 days, from 1 hour to 5 days, from 1 hour to 3 days, from 2 hours to 10 days, from 2 hours to 7 days, from 2 hours to 5 days, from 2 hours to 3 days, from 4 hours to 10 days, from 4 hours ΐο 7 days, from 4 hours to 5 days, from 4 hours to 3 days, from 8 hours to 10 days, from 8 hours to 7 days, from 8 hours to 5 days, from 8 hours to 3 days, from 12 hours to 10 days, from 12 hours to 7 days, from 12 hours to 5 days, from 12 hours to 3 days, from 1 8 hours to 10 days, from 1 8 hours to 7 days, from 18 hours to 5 days, from 1 hours to 3 days, from 24 hours to 10 days, from 24 hours to 7 days, from 24 hours to 5 days, or from 24 hours to 3 days. The temperature of the combined mixture of ZIF ¹ with the liquid composition comprising IM ^b may range, for example, from a temperature of about -78°C (dry-ice bath temperature) to the boiling temperature of the solvent (the normal boiling point of N.A -dimethylformamidc is about 153°C), from about () ^D C (ice water bath temperature) to at least 10°C below the boiling temperature of the solvent, or from about 15°C to at least 15°C below the boiling temperature of the solvent (or alternately to about 100°C). When contact takes place in a pressurized vessel, the temperature may exceed the boiling temperature of the solvent. For example, the contact may take place at room temperature or greater, such as from about 18°C to about 200°C or from about 75°C to about 150°C. In certain embodiments where complete or substantially (e.g., 90% or greater) complete exchange of IM ^a with lM ^b is desired, the time of contact may be from 20 hours to 72 hours and the temperature of contact may be from 130°C to 1 50°C.

[00631 After ZIF ¹ is exchanged with lM ^b to form Z1F ² , the ZIF ² may be recovered and treated, if necessary or desired (e.g., to remove molecules from the pore space of the ZIF"). This treatment may involve techniques for activating the as-synthesized form of a ZIF prepared by solvothermal methods, for example, as described in U.S. Patent Application Publication Nos. 2007/0202038 and 2009/021 1440. For example, the recovered ZIF ² may be w'ashed with DMF, solvent exchanged with acetonitrile (e.g., 3 exchanges in -3 days) and dried, for example, under vacuum at about 200°C for -3 hours. T he dried product may then be soaked in acetonitrile, e.g. , at ~75°C for -24 hours, followed by a final rinse with fresh acetonitrile, to produce the acetonitrile- exchanged product. Finally the acetonitrile-exchanged product may be placed under vacuum, e.g. , less than about 10 mTorr at ~70°C for about 10-18 hours, to yield the activated form of ZIF".

[0064] M ¹ and M ² may be one or more transition metals as described for ZIFs in U.S. Patent Application Publication No. 2007/0202038. Such transition metals can include, but are not necessarily limited to, Sc, Ti. V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Y. Zr, Nb. Mo, Tc, Ru, Rh, Pd, Ag, Cd, Lu, Hf, Ta. W, Rc, Os, lr, Pt, Au, Hg, Lr, Rf, Db, Sg, Bh, Hs, Mt, Ds, Rg, and Uub.

[0065] IV] ¹ and M ² may additionally or alternately comprise other metals. For example, as described in U.S Patent Application Publication No. 20 10/0307336, M ¹ may be a metal having a first valency, and M ² may be a metal having a second valency different from said first valency.

[0066] In one such embodiment, M ¹ may be a monovalent metal cation, including Li ^h , Na ⁺ , ⁺ , Cs ⁺ , Rb ⁺ , Cu ' , Ag ⁺ , and/or Au ⁺ (e.g. , including or being Li ⁺ , Cu' , and/or Ag ^÷ , particularly including or being LP). Additionally or alternately, in such an embodiment, M ^~ may be a trivalent element cation, including B ^{J t} , ΑΓ ^" , Ga ^J+ , In ^J+ , Fe ³ Cr ³⁺ , So ^" , Y ³⁺ , and/or La ³⁺ , wherein La is any lanthanide metal (e.g. , including B ⁺ , Al ⁺ , and/or Ga ⁺ , particularly including B ³⁺ ).

[0067] In certain embodiments, M ¹ and M ² may both be the same. When M ^! and M ² are both the same, they may advantageously comprise or be a transition metal, for example Zn.

[0068J The zeolitic imidazolatc framework materials described herein, e.g. , ZIF ¹ and ZIF ² , may have a tetrahedrai framework comprising a structure selected from the group consisting of IV, V, VI, or any combination thereof:

wherein A ¹ , A ² . A ³ , and A ⁴ can each independently be selected from the group of elements consisting of C, N, P, and B, and each of A ³ , A ⁶ , and A ⁷ can be cither C or N; wherei ·n R5 -R8 can i*ndi·vi"dually be present when thei ·r correspondi 'ng A1 -A compri-ses C; wherein R ¹ , R ⁴ , and/or R ⁹ may advantageously comprise a non-stcrically hindering group that does not (substantially) interfere with the adjacent M or NT; wherein R and R ^J , as well as R , R , R , and/or R , when present, may each individually be hydrogen, alkyl, halo, cyano, or nitro; wherein M ¹ and M ² may comprise the same or different metal cation; and wherein R ¹⁰ -R ¹² can individually be present when their corresponding A ⁵ -A ⁷ comprises C, in which case one or more of R ¹⁰ -R ¹² being present can optionally but advantageously be electron withdrawing groups.

[0069] In one embodiment, each of R ¹ , R ⁴ , and R ⁹ can be independently selected from hydrogen, methyl, ethyl, nitro, formyl, halo, and cyano groups.

[0070] Suitable electron withdrawing groups for each of R ¹⁰ , R ^{1 1} , and R ¹² can include, but are not necessarily limited to, nitro, cyano, fluoro, and chloro groups.

[0071] According to an example of a particular embodiment, the first zeolitic imidazolate framework composition may comprise the structure of formula IV, and the second zeolitic imidazolate framework composition may comprise the structure of formula V.

[0072] Examples of family members of the zeolitic imidazolate framework materials described herein can comprise structures selected from the group consisting of VII, VIII, IX, X, XI, XII, XIII, XIV, XV, XVI, XVII, XVIII, and combinations thereof:

(XVI I I)

H3C CH3

[0073] The imidazolate linking moieties in the above formulae have been successfully used in the conventional syntheses of ZIFs, for example as reported by Yaghi and his co-workers in the following publications: "Exceptional Chemical and Thermal Stability of Zeoiitic Imidazolate Frameworks", Proceedings of the National Academy of Sciences of U.S.A ., Vol. 103, 2006, pp. 1 0186-91 ; "Zeolite Λ Imidazolate Frameworks", Nature Materials, Vol. 6. 2007. pp. 501 -6; ''High-Throughput Synthesis of Zeoiitic Imidazolate Frameworks and Application to CO ₂ Capture ^" , Science, Vol. 319, 2008, pp. 939-43 ; "Colossal Cages in Zeoiitic Imidazolate Frameworks as Selective Carbon Dioxide Reservoirs", Nature, Vol. 453. 2008, pp. 207- 1 2; and "Crystals as Molecules: Postsynthesis Covalent Functionalization of Zeoiitic

Imidazolate Frameworks", Journal of the American Chemical Society, Vol. 130, 2008, pp. 12626-7, inter alia.

[0074] According to examples of particular embodiments of the exchange method described herein, the first zeoiitic imidazolate framework cemposition may comprise a struclure of formulae VII. VIII, IX, X, XI, and/or XII (e.g. , the structure of formula VIII). and the second zeolitic imidazolate framework composition may comprise a structure of formulae XIII, XIV, XV, XVI, XVII. and/or XVIII (e.g. , of formulae XIII, XIV, XV, and/or XVI, or of formula XV).

C. ZIF Structures and Uses

[0075] The zeolitic imidazolate framework materials disclosed herein may have tetrahedral framework structures of any type. The framework types of the zeolitic imidazolate framework materials are denoted herein by a code consisting of three upper-case letters, in a similar manner to that used in the zeolite literature. It must be pointed out that a system of three-lower-case-letter symbols was introduced by

O'Kceffe and Yaghi for the designation of the framework types of metal-organic frameworks (MOFs), meta-organic polyhedra (MOPs), zeolitic imidazolate frameworks (ZIFs), and covalcnt-organic frameworks (COFs). General information about the latter can be found, for example, in the publication by O ^' ecffc and Yaghi et al , ''Reticular Chemistry: Occurrence and Taxonomy of Nets and Grammar for the Design of

Frameworks ^" , Accounts of Chemical Research, Vol. 38, 2005, pp. 176-82, and at http://rcsr.anu.edu.au/home, the Reticular Chemistry Structure Resource (RCSR) website. For the purpose of uniformity, all framework type codes used in this publication are in upper-case letters. It is also noted that the concepts "framework type", ''framework structure ^"1 , "topology ^" , and ' ^" net ^" are used essentially

interchangeably in the relevant literature.

|G076[ ZIFs can include such structures iso-structural to known zeolites and related minerals, as well as structures unique to the field of ZIFs, for example, those identified in U.S. Patent Application Publication Nos. 2007/0202038 and 2010/0307336, including ABW, AGO, AEI, AEL, AEN, AET, AFG, AFI, AFN. AFO. AFR, AFS, AFT, A FX, AFY, AHT, ANA, APC. APD, AST, ASV, ATN, ΑΊΌ, ATS, ATT, ATV, A WO, AWW, BCT, BEA, B EC, Bi , BOG, Β1Ή. BRE, GAG, CAN, CAS, CDO, CFI, CGF, CGS, CHA, CHI, CLO, CON, CRB, CZP, DAC, DDR, DFO, DFT, DIA, DOH, DON, ΕΛΒ. EDI. EMT, EON, EPF ERI, ESV. ETR. EUO. EZT, FAR, FAU. FER. FRA, FRL, GIS, GIU, GME, GON, GOO, HEU, IFR, IHW, ISV, ITE, ITH, ITW, IWR, IWV, IWW, JBW, KFI, LAU, ECS. EEV, LIO, LIT, LOS, LOV, LTA, LTL, LTN, MAR, MAZ, MET, MEL, MEP, MER, MFI, MFS, MON, MOR, MOZ, MSE, MSO, MTF. MTN, MTT, MTW, MWW, NAB, NAT, NES, NON, NPO, NSI, OBW, OFF, OSI, OSO, OWE, PAR, PAU, PHI, PON, POZ, RHO, RON, RRO, RSN, RTE, RTH, RUT, RWR, RWY, SAO, SAS, SAT, SAV, SBE, SBS, SBT, SEE, SFF, SFG, SFH, SEN, SFO, SGT, SIV. SOD, SOS, SSY, S I F, STI, STT, SZR, TER, TI 10, TON, TSC. TUN, UEI, UFI, UOZ, USI, UTL, VET, VFI, VNI, VSV, WEI, WEN, YUG, ZNI, and ZON. Such structures can include a tctrahedral iramework type selected from the group consisting of CRB, DFT, CAG. SOD, MER, RHO, ANA, LTA, DIA, ZNI, GME, ECS, FRL, GIS, POZ, MOZ, and combinations thereof.

[0077] The present porous crystalline materials in the as-synthesized form can generally contain guest species, typically solvent and/or template molecules, within the tetrahedral frameworks. The guest species can be removed, e.g. , by evacuation at a relatively low pressure (such as less than 50 mTorr) and optionally but typically at a temperature from about 70°C to about 300°C, or alternately by exchange with an organic solvent of relatively small molecular size (e.g., acetonitrile), followed by evacuation, such as using the previously described process. The removal of guest species can result in an increase in internal pore volume that can be used to adsorb various gases, such as carbon dioxide, carbon monoxide, sulfur dioxide, sulfur trioxide, hydrogen sulfide, hydrocarbons, hydrogen, nitrogen, oxygen, noble gases, ammonia, amines, or combinations thereof.

[0078] Zeolitic imidazolate framework materials, e.g. , prepared by the exchange method described herein, such as those having the SOD framework type and/or the empirical formula of Zn(5-azabenzimidazolc)2, may have unique carbon dioxide sorption capacities. For example, under conditions comprising a temperature of 28°C, the zeolitic imidazolate framework material may sorb: (i) at least 0.30 mmol of C per gram of zeolitic imidazole framework composition (e.g. , at least 0.35 mmol/g, at least 0.40 mmol/g, at least 0.45 mmol/g, at least 0.50 mmol/g, at least 0.55 mmol/g, at least 0.60 mmol/g, at least 0.65 mmol/g, at least 0.70 mmol/g, at least 0.75 mmol/g, at least 0.80 mmol/g, at least 0.85 mmol/g, at least 0.90 mmol/g, at least 0.95 mmol/g, or at least 1 .0 mmol/g) at a C0 ₂ partial pressure of -75 Torr; fii ) at least 0.35 mmol of C0 ₂ per gram of zeolitic imidazole framework composition (e.g. , at least 0.40 mmol/g, at least 0.45 mmol/g, at least 0.50 mmol/g, at least 0.55 mmol/g, at least 0.60 mmol/g, at least 0.65 mmol/g, at least 0.70 mmol/g, at least 0.75 mmol/g, at least 0.80 mmol/g, at least 0.85 mmol/g, at least 0.90 mmol/g, at least 0.95 mmol/g, at least 1.0 mmol/g, at least 1.1 mmol/g, at least 1 .2 mmol/g, or at least 1 .3 mmol/g) at a C0 ₂ partial pressure of -100 Torr; and/or (iii) at least 0.50 mmol of C0 ₂ per gram of zeolitic imidazole framework composition (e.g., at least 0.55 mmol/g, at least 0.60 mmol/g, at least 0.65 mmol/g, at least 0.70 mmol/g, at least 0.75 mmol/g, at least 0.80 mmol/g, at least 0.85 mmol/g, at least 0.90 mmol/g, at least 0.95 mmol/g, at least 1 .0 mmol/g. at least 1.1 mmol/g, at least 1.2 mmol/g, at least 1.3 mmol/g, at least 1 .4 mmol/g, at least 1.5 mmol/g, at least 1.6 mmol/g, at least 1 .7 mmol/g, or at least 1.8 mmol/g) at a C0 ₂ partial pressure of -200 Torr. Though there is not necessarily an upper limit on C0 ₂ sorption capacity, at the relatively low partial pressures listed here, the zeolitic imidazolate framework materials according to the invention can typically sorb up to 5 mmol/g C0 ₂ .

[0079] Additionally envisioned are Z1F materials, e.g., prepared by the exchange method described herein, such as those having the SOD framework type and/or the empirical formula of Zn(5-azabenzimidazole) ₂ , that additionally contain at least 0.30 mmol of sorbed C0 ₂ per gram of zeolitic imidazole framework composition (e.g., at least 0.35 mmol/g, at least 0.40 mmol/g, at least 0.45 mmol/g, at least 0.50 mmol/g. at least 0.55 mmol/g, at least 0.60 mmol/g, at least 0.65 mmol/g, at least 0.70 mmol/g, at least 0.75 mmol/g, at least 0.80 mmol/g, at least 0.85 mmol/g, at least 0.90 mmol/g, at least 0.95 mmol/g, at least 1.0 mmol/g, at least 1 .1 mmol/g, at least 1.2 mmol/g, at least 1 .3 mmol/g, at least 1.4 mmol/g, at feast 1 .5 mmol/g, at least 1 .6 mmol/g, at least 1.7 mmol/g, at least 1 .8 mmol/g, at least 1 .9 mmol/g, at least 2.0 mmol/g, at least 2.1 mmol/g, at least 2.2 mmol/g, at least 2.3 mmol/g, at least 2.4 mmol/g, or at least 2.5 mmol/g).

[0080] Additionally or alternately, the present invention can include one or more of the following embodiments.

[0081 ] Embodiment 1. A method for exchanging imidazolate linker in a zeolitic imidazolate framework composition, said method comprising the steps of: (a) providing a first zeolitic imidazolate framework composition having a tetrahedral framework comprising a general structure, M' -IM ^a -M ² , wherein ¹ and M ² comprise the same or different metal cations, and w†ierein lM ^d is an imidazolate or a substituted imidazolate linking moiety; (b) providing a liquid composition comprising IM ^b , wherein lM ^b is an imidazolate or a substituted imidazolate which is different from IM ^a ; and (c) contacting the first zeoiitic imidazolate framework composition with the liquid composition under conditions sufficient to exchange at least a portion of IM* with at least a portion of lM ^b and to produce a second zeoiitic imidazolate framework composition, M '-IM ^C -M ² , wherein IM ^C comprises I ^b , and wherein the framework type of the second zeoiitic imidazolate framework composition is different from the framework type obtained when a zeoiitic imidazolate framework composition is prepared by crystallizing a liquid reaction mixture comprising a solution of M ¹ , M ² and lM ^b .

[0082] Embodiment 2. A method according to embodiment 1 , wherein the framework type of the first zeoiitic imidazolate framework composition is the same as the framework type of the second zeoiitic imidazolate framework composition and/or wherein both of the first and second zeoiitic imidazole framework compositions comprise at least one transition metal (e.g., selected from the group consisting of Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Y, Zr, Nb. Mo, Tc, Ru, Rh, Pd, Ag, Cd, Lu, Hf, Ta, W, Re, Os, Ir, Pt, Au, Hg, Lr, Rf, Db, Sg, Bh. Hs, Mt, Ds, Rg, Uub, and combinations thereof).

[0083J Embodiment s. A method according to embodiment 1 or embodiment 2, wherein the first zeoiitic imidazolate framework composition comprises less than 1 mole percent of IM , based on the total moles of lM ^a and IM ^b in the first zeoiitic imidazolate framework composition, wherein the liquid composition comprises less than 1 mole percent of IM ^il , based on the total moles of lM ^a and IM ^b in the liquid composition, and wherein the second zeoiitic imidazolate framework composition comprises at least 10 mole percent (e.g., at least 50 mole percent or at least 90 mole percent) of IM ^b , based on the total moles of IM ^a and IM ^b in the second zeoiitic imidazolate framework composition.

[0084] Embodiment 4. A method according to any one of the previous

embodiments, wherein both of the first and second zeoiitic imidazolate framework compositions: have a framework type selected from the group consisting of ABW, ACO, AE1, AEE, AEN, AET, AFG, AFL AFN, AFO, AFR, AFS, AFT, AFX, AFY, AHT. ANA, APC, APD, AST, ASV. ATN. ATO, ATS, ATT, ATV, A WO. AWW, BCT, BEA, BEC, BI , BOG. BPH, BRE, CAG. CAN, CAS, CDO, CFI. CGF. CGS, CHA, CEIL CLO, CON, CRB, CZP, DAC, DDR, DFO, DFT, DIA, DOH, DON. EAB, EDI, EMT, EON, EPI, ERI, ESV, ETR, EUO, EZ I , FAR, FAU, EER, FRA, FRE, GIS, GIU, GME, GON, GOO, HEU, IFR, IHW, ISV, ITE, ΙΊΉ, ITW, IWR, IWV, IWW, JBW, KFi, LAU, LCS, LEV, LIO, LIT, LOS, LOV, LTA, LTL, LTN, MAR, MAZ, MEL MEL, MEP, MER, MFI, MFS, MON, MOR, MOZ, MSE, MSO, MTF, MTN, MTT, MTW, MWW, NAB, NAT, NES, NON, NPO, NSI, OBW, OFF, OSI, OSO, OWE, PAR, PAU, PHI, PON, POZ, RHO, RON. RRO, RSN, RTE, RTH, RUT, RWR, RWY, SAO, SAS, SAT, SAV, SBE, SBS, SBT, SFE, SFF, SFG, SFH, SEN, SFO, SGT, SIV, SOD, SOS, SSY, STF, STI, STT, SZR, TER. THO, TON, TSC, TUN, UEL UFI, UOZ, USE UTL, VET, VFl, VNI, VSV, WEI, WEN, YUG, ZNI, ZON, and combinations thereof (e.g. , selected from the group consisting of CRB, DFT, CAG, SOD, MER, RHO, ANA, LTA. DIA, ZNI, GME, LCS, FRL, GIS, POZ, MOZ, and combinations thereof); are porous crystalline materials having a tetrahedral framework comprising a structure selected from the group consisting of IV, V, VI, or any combination thereof:

^■ J j-

wherein A ¹ , A ² , A ³ and A ⁴ are selected from a group of elements consisting of C, N, P, and B, wherein A ^s , A ⁶ , and A ⁷ can be either C or N, wherein R^-R ⁸ are present when A ^! to A ⁴ comprise C, wherein R ¹ , R ⁴ or R ⁹ comprise a non-sterically hindering group that does not interfere with the adjacent ¹ or M ² . wherein R\ R ³ , R ³ , R ⁶ , R ⁷ . and R ⁸ are each individually hydrogen, alkyl, halo, cyano, or nitro, wherein M ¹ and M ² comprise the same or different metal cation, and wherein R ¹⁰ , R ⁿ , and R ¹² are each individually electron withdrawing groups (e.g. , wherein the first zeolitic imidazolate framework composition comprises the structure of formula IV, and the second zeolitic imidazolate framework composition comprises the structure o formula V).

[0085 j Embodiment 5. A method according to embodiment 4, wherein both the first and second zeolitic imidazolate framework compositions are porous crystalline materials having a tetrahedral framework comprising a structure selected from the group consisting of VII, VIII, IX, X, XI, XII, XIII, XIV, XV, XVI, XVII, and/or XVIII:

II)

(XV ! I l)

H ₃ C CH ₃

[0086] Embodiment 6. Λ method according to embodiment 5, (i) wherein the first zeolitic imidazolate framework composition comprises the structure of formulae VII, VIII, IX, X, XL and/or XII, and the second zeolitic imidazolate framework composition comprises the structure of formulae XIII, XIV, XV, XVI, XVII, and/or XVIII; (ii) wherein the first zeolitic imidazolate framework composition comprises the structure of formula VI II, and the second zeolitic imidazolate framework composition comprises the structure of formulae XIII, XIV, XV, and/or XVI; and/or (iii) wherein the second zeolitic imidazolate framework composition comprises the structure of formula XV . [0087] Embodiment 7. Λ method according to any one of the previous

embodiments, wherein IM comprises a functionality lacking in lM ^a , wherein said functionality has an affinity for adsorbing a gas (e.g. , wherein said functionality comprises or is a Lewis base functionality and wherein said gas comprises or is a Lewis acid or a molecule with an electrophilic center; wherein said functionality is a Lewis base functionality in a benzamidazolatc and wherein said gas comprises or is CO?; or wherein said functionality comprises or is a Lewis acid functionality, and wherein said gas comprises or is a Lewis base).

[0088] Embodiment 8. A method according to any one of the previous

embodiments, (i) wherein the first zeolitic imidazolate framework composition is Z1F-8 comprising a 2-methylimidazolate linker, wherein the second organic linker composition is benzimidazolate, wherein the second zeolitic imidazolate framework composition is ZIF-7 comprising a benzimidazolate linker; or (ii) wherein the first zeolitic imidazolate framework composition is ZIF-8 comprising a 2-methylimidazolatc linker, wherein the second organic linker composition is 5-azabenzimidazolate, wherein the second zeolitic imidazolate framework composition comprises a 5- azabenzimidazolate linker, and wherein both the first and second zeolitic imidazolate framework compositions have an SOD framework type.

[0089] Embodiment 9. A zeolitic imidazolate framework composition with an SOD framework type, wherein the zeolitic imidazolate framework structure is capable of adsorbing, at a temperature of ~28°C: (i ) at least 0.30 mmol of C0 ₂ per gram of zeolitic imidazolate framework composition (e.g. , at least 0.35 mmol/g, at least 0.40 mmol/g, at least 0.45 mmol/g, at least 0.50 mmol/g, at least 0.55 mmol/g, at least 0.60 mmol/g, at least 0.65 mmol/g, at least 0.70 mmol/g, at least 0.75 mmol/g, at least 0.80 mmol/g, at least 0. 5 mmol/g, at least 0.90 mmol/g, at least 0.95 mmol/g, or at least 1 .0 mmol/g) at a C0 ₂ partial pressure of -75 Torr; (ii) at least 0.35 mmol of CO? per gram of zeolitic imidazolate framew ^r ork composition (e.g. , at least 0.40 mmol/g. at least 0.45 mmol/g, at least 0.50 mmol/g, at least 0.55 mmo!/g, at least 0.60 mmol/g, at least 0.65 mmol/g, at least 0.70 mmol/g, at least 0.75 mmol/g. at least 0.80 mmol/g. at least 0.85 mmol/g, at least 0.90 mmol/g, at least 0.95 mmo!/g, at least 1 .0 mmol/g, at least 1 .1 mmol/g, at least 1 .2 mmol/g, or at least 1 .3 mmol/g) at a CO ₂ partial pressure of -100 Torr; and/or (iii) at least 0.50 mmol of CO ₂ per gram of zeolitic imidazolate framework composition (e.g., at least 0.55 mmol/g, at least 0.60 mmol/g, at least 0.65 mmol/g, at least 0.70 mmol/g, at least 0.75 mmol/g, at least 0.80 mmol/g, at least 0.85 mmol/g, at least 0.90 mmol/g, at least 0.95 mmol/g, at least 1.0 mmol/g, at least 1 .1 mmol/g, at least 1.2 mmol/g, at least 1.3 mmol/g, at least 1 .4 mmol/g, at least 1.5 mmol/g, at least 1 .6 mmol/g, at least 1 .7 mmol/g, or at least 1 .8 mmol/g) at a CO ₂ partial pressure of -200 Torr.

[0090] Embodiment 10. A zeo!itic imidazolate framework composition having an empirical formula, Zn(5-azabenzimidazolate)2, wherein the zeolitic imidazolate framework structure is capable of sorbing, at a temperature of ~28°C: (i) at least 0.30 mmol of CO ₂ per gram of zeolitic imidazolate framework composition (e.g. , at least 0.35 mmol/g, at least 0.40 mmol/g, at least 0.45 mmol/g, at least 0.50 mmoi/g, at least 0.55 mmol/g, at least 0.60 mmol/g, at least 0.65 mmol/g, at least 0.70 mmol/g, at least 0.75 mmol/g, at least 0.80 mmol/g, at least 0.85 mmol/g, at least 0.90 mmol/g, at least 0.95 mmol/g, or at least 1 .0 mmol/g) at a C0 ₂ partial pressure of ~75 Torr; (ii) at least 0.35 mmol of C0 ₂ per gram of zeolitic imidazolate framework composition (e.g. , at least 0.40 mmol/g, at least 0.45 mmol/g, at least 0.50 mmol/g, at least 0.55 mmol/g, at least 0.60 mmol/g, at least 0.65 mmol/g, at least 0.70 mmol/g, at least 0.75 mmol/g, at least 0.80 mmol/g, at least 0.85 mmol/g, at feast 0.90 mmol/g, at least 0.95 mmol/g, at least 1 .0 mmol/g, at least 1 .1 mmol/g, at least 1 .2 mmol/g, or at least 1.3 mmol/g) at a CO ₂ partial pressure of - 100 Torr; and/or (iii) at least 0.50 mmol of C0 ₂ per gram of zeolitic imidazolate framework composition (e.g. , at least 0.55 mmol/g, at least 0.60 mmol/g, at least 0.65 mmol/g, at least 0.70 mmol/g, at least 0.75 mmol/g, at least 0.80 mmol/g, at least 0.85 mmol/g, at least 0.90 mmol/g, at least 0.95 mmol/g, at least 1 .0 mmoi/g, at least 1 .1 mmoi/g, at least 1.2 mmol/g, at least 1 .3 mmol/g, at least 1 .4 mmol/g, at least 1 .5 mmol/g, at least 1 .6 mmol/g, at least 1 .7 mmo!/g, or at least 1.8 mmol/g) at a C0 ₂ partial pressure of -200 Torr.

[0091 ] Embodiment 1 1 . A composition of matter having an empirical formula Zn(5-azabenzimidazolate) ₂ and exhibiting an SOI) framework type.

[0092J Embodiment 12. A composition of matter according to any one of embodiments 9- 1 1 , further comprising at least 0.30 mmol of sorbed CO ₂ per gram of zeolitic imidazolate framework composition (e.g. , at least 0.35 mmol/g, at least 0.40 mmol/g, at least 0.45 mmol/g, at least 0.50 mmol/g, at least 0.55 mmol/g, at least 0.60 mmol/g, at least 0.65 mmol/g, at least 0.70 mmol/g, at least 0.75 mmol/g, at least 0.80 mmol/g, at least 0.85 mmol/g, at least 0.90 mmol/g, at least 0.95 mmol/g, at least 1.0 mmol/g, at least 1 .1 mmol/g, at least 1 .2 mmol/g, at least 1 .3 mmol/g, at least 1.4 mmol/g, at least 1.5 mmol/g, at least 1.6 mmol/g, at least 1.7 mmol/g, at least 1.8 mmol/g, at least 1.9 mmol/g, at least 2.0 mmol/g, at least 2.1 mmol/g, at least 2.2 mmol/g, at least 2.3 mmol/g, at least 2.4 mmol/g, or at least 2.5 mmol/g).

[0093] Embodiment 13. A method of adsorbing a gas comprising contacting the porous crystalline material of any one of embodiments 9- 12 with a gas (e.g. , comprising hydrogen, nitrogen, oxygen, a noble gas, carbon monoxide, carbon dioxide, sulfur dioxide, sulfur trioxide, hydrogen sulfide, ammonia, a hydrocarbon, an amine, or a combination thereof).

[0094] Embodiment 14. A method of separating a gas (e.g. , comprising hydrogen, nitrogen, oxygen, a noble gas, carbon monoxide, carbon dioxide, sulfur dioxide, sulfur trioxide, hydrogen sulfide, ammonia, a hydrocarbon, an amine, or a combination thereof) from a fluid stream containing the gas comprising contacting the fluid stream with the porous crystalline material of any one of embodiments 9-12.

[0095] The invention will now be more particularly described with reference to the Examples and the accompanying drawings.

EXAMPLES

[0096] In the Examples, all chemicals used in the synthesis of materials were commercial grade and purchased from Aldrich, except as noted: zinc nitrate tetrahydrate (EM Science, 98.5%), benzimidazole (98%), 4-azabenzimidazole (99%), 5-azabcnzimidazole (97%), purine (98%), N,iV-dimethylformamide (99.8%), triethylamine (99.5%), acetomtrilc (99.5%), chloroform (99.8%), zinc oxide (99.9%). Ail chemicals w ^r ere handled in air.

[0097] Z1E-8, in the activated form (i. e. , with solvent molecules substantially removed), was purchased from Aldrich under the brand name Basolite Z 1200. ZIF-7 w ^: as synthesized and activated according to the procedure disclosed in U.S. Patent Application Publication No. 2009/021 1440. Activated Z1F-8 and ZIF-7 are both believed to be highly hydrophobic solids, and thus were stored under ambient condition and handled in air. ZIF-8 is a material having the empirical formula Zn(2-methyl imidazolate)2 and the framework type SOD. ZIF-7 is a material having the empirical formula Zn(benzimidazolate)2 and the framework type SOD. Although both materials are of the same framework type, they should be relatively easily differentiated by- powder X-ray diffraction, due to the different symmetries of the framework.

[0098] The reaction vessels used in the Examples were ~23-mL or ~45-mL Parr Acid Digestion Bombs with PTFE liners. For larger quantity reactions, a Parr Pressure Reactor (autoclave) with PTFE liner and Series 4843 temperature controller was used.

[0099J The powder X-ray diffraction patterns were measured on a PANalytical X'Pert di fractometer equipped with an X'celerator detector in Bragg-Brentano geometry using Cu Ka radiation (-45 kV and -40 mA tube voltage and current), a -1/4° fixed divergence slit, and a -0.017° step size for the two-theta range from -3 to -50 degrees. All data processing was conducted using Materials Data JADE 9 software.

[00100) Quantitative ^{| J} C MAS NMR spectra were acquired using a Varian lnfinityPlus-500 wide bore spectrometer operating at a static magnetic field of ~1 1.74 T, corresponding to a Larmor frequency of about 125 MHz and about 500 MHz for ^{l j} C and 'H, respectively. The spectra were recorded using -4 microsecond 90-degree pulse,—60- 120 second pulse repetition delay on samples loaded in ~5-mm (o.d.) rotors, spinning at a magic angle rate of about 9.5 kHz, and ^l l l decoupling during data acquisition. Chemical shi fts shown are relative to tetramethylsilane (TMS, 6 ^' _C - 0 ppm). Activated ZIF samples were used for the measurements and a typical sample size was about 75-105 mg, although samples as small as about 10 mg can easily be tested.

[00101] The gas sorption measurements were conducted on a Quantachrome Autosorb- 1™ automatic gas sorption analyzer. The instrument measures pressure differences due to sorption (in this case physical adsorption and desorption) at the gas/solid interface. At a specified temperature, and using the non-ideality correction factor of the gas at that temperature, the instrument utilizes a proprietary algorithm from basic gas laws to calculate the volume of gas adsorbed onto, and desorbed from, the solid adsorbent for each pressure selected by the user. Volume o gas is converted into millimoles (mmol) and scaled to the weight of adsorbent, resulting in the common units of adsorption (i.e. , mmol gas divided by grams of adsorbent, or mmol/g). A plot of amount adsorbed versus pressure, at constant temperature, can represent the sorption isotherm of a particular gas/solid interface. All isotherms were measured at ~-28°C for a single-component gas adsorbate for pressures up to about 760 Torr. Before each isotherm measurement, a sample of about 50-100 mg of an activated ZIF material was outgassed on the pre-treatment station of the Autosorb-1™ under relatively high vacuum (less than 10 mTorr) at about 65-70°C for about 10- 18 hours.

Example 1 : Exchange of ZIF-8 (Zn(2-methylimidazolate) ₂ ) to form ZIF-7

{Zn(benzimidazolate) ₂ )

[00102] About 240 mg of ZIF-8, -415 mg benzimidazole, and ~5 mL DMF were thoroughly mixed in an NMR sample tube. The sample tube was then subjected to five heating cycles as described below. In a first cycle, the sample tube was placed in an oil bath at a first temperature (ΙΊ) of ~26°C (i. e. , approximately room temperature). After a short period of time sufficient to achieve a sample temperature of ~26°C, the sample was inserted into an NMR probe and was maintained at the same temperature of ~26°C. In subsequent cycles, the oil bath was maintained at higher temperatures, and the sample was heated in the oil bath for longer time periods, e.g. , ranging from 1 8 to 21 hours, as specified below. In each cycle, the NMR sample tube was inserted into an NMR probe sitting at a pre-set temperature, which was the same as that of the oil bath, e.g. , (T| ) for the first cycle. Ή NMR and °C NMR at spinrate ~ 0 Hz were recorded in each cycle. The transfer time from the oil bath to the NMR probe at the same temperature was kept to less than 10 minutes in each cycle. After recording the NMR spectra, the next cycle was initiated by ejecting the sample tube from NMR probe and moving the sample tube to oil bath at a higher temperature, e.g. , (T ₂ ) for the second cycle. The transfer time from the NMR probe to the oil bath was less than 4 minutes in each cycle. In the first cycle, the temperature ( ΙΊ) of the oil bath and the NMR probe was ~26°C. In the second cycle, the temperature (T ₂ ) of the oil bath and the NMR probe was ~40°C, and the sample tube was heated in the oil bath for about 18 hours. In the third cycle, the temperature (T3) of the oil bath and the NMR probe was ~60°C, and the sample tube was heated in the oil bath for about 19 hours. In the fourth cycle, the temperature (T ₄ ) of the oil bath and the NMR probe was -80°C, and the sample tube was heated in the oil bath for about 21 hours. In the fifth cycle, the temperature (T ₅ ) of the oil bath and the NMR probe was ~100°C, and the sample tube was heated in the oil bath for about 19 hours.

[00103] The 125-MHz liquid-state ^U C NMR spectra are shown in Figure 1 , and results obtained from the spectra are shown in Figure 2. In Figure 1 , the bottom line represents the spectra for the first cycle at -26°C, the line second from the bottom represents the spectra for the second cycle at ~40°C, the middle line represents the spectra for the third cycle at ~60°C, the line second from the top line represents the spectra for the fourth cycle at ~80°C, and the top line represents the spectra for the fifth cycle at ~100°C. Certain relevant sections of the spectra are highlighted by shaded regions in Figure 1.

[00104] In this Example, the intensity was observed to change as a function of time for relevent portions of the spectra, as shown. In Figure 2, intensity changes were shown relative to the -30 ppm peak arbitrarily set at 1000 counts. In Figure 2, day zero represented the spectra for cycle 1 , day 1 represented the spectra for cycle 2, day 2 represented the spectra for cycle 3, day 3 represented the spectra for cycle 4, and day 4 represented the spectra for cycle 5. The effective exchange of imidazolate linkers, as observed through the disappearance of benzimidazole from, and the appearance of 2- methyl imidazole in, the DMF solvent, can be conveniently seen by the signals at ~1 15 ppm and -138 ppm (characteristic of benzimidazole), and at -13 ppm, -121 -122 ppm, and -141 ppm (characteristic of 2-methyl imidazole), respectively.

[00105] After cycle 5, the solid product w ^: as recovered by thoroughly washing with fresh D F (-5 ml 3). As indicated by the powder X-ray diffraction patterns shown in Figure 3, the product was identified as comprising ZIF-7, which has the empirical formula Zn(benzimidazolate)2 and the framework type SOD, along w ^r ith some residual unconverted ZIF-8 (which also has the SOD framework type).

Example 2: Exchange of ZI F-8 (Zn(2-methylimidazolate)2) to form EMM-19

(Zn(5-azabenzimidazolate)2)

[00106] A clear solution o - 1 .00 g 5-azabenzimidazole in - 1 0 mL DMF was prepared in a glass vial, and then added to ~1 00 mg of solid ZIF-8, which was previously weighed out in a PTFE cup of a ~45-mL Parr bomb. The Parr bomb was then sealed and heated in an isothermal oven at ~140°C for about 24 hours. Alter reaction, the Parr bomb was removed from the oven and allowed to cool naturally to ambient temperature (about 25°C). Then, the Parr bomb was opened, the mother liquor decanted, and the solid product washed thoroughly with DMF (~5 raL ^x 3) and stored in DMF. The product was designated herein as E M-19.

[00107] Figure 4 compares the powder X-ray diffraction patterns of EMM-19 and ZIF-7, both in the as-synthesized form. The excellent agreement of the patterns supports the conclusion that these two materials have the same framework type (SOD). EMM- 19, which has the empirical formula Zn(5-azabenzimidazolate) ₂ and the framework type SOD, is believed to be a new composition of matter. As reflected in the literature, when 5-azabenzimidazolate is used to form a ZIF by a conventional solvothennal crystal ization technique, the resulting ZIF has been known to exhibit only the framework type LTA.

[00108] The as-synthesized EMM- 19 w ^r as activated by using the same method as that for as-synthesized ZIF-7, which was disclosed in U.S. Patent Application

Publication No. 2009/021 1440. Specifically. (1 ) a sample of about 100 mg of the as- synthesized EMM- 19 was immersed in about 15 mL acetonitrile (3 times in ~3 days) at ambient temperature (about 20-25 °C) to achieve a partial exchange of the DMF solvent molecules occluded in the pores; (2) the solvent was decanted and the sample was dried under vacuum at ~200°C for ~3 hours; (3) the dried sample was soaked in -10 mL acetonitrile at ~75°C for ~24 hours and then rinsed with fresh acetonitrile; and (4) the acetonitrile-exchanged sample was placed under vacuum (less than about 10 mTorr) at ~70°C for about 10 hours to yield activated EMM- 19.

[00109] The activated EMM-19 was stored under ambient conditions and used for further experiments described below, including solid-state NMR (Example 3), gas adsorption/desorption (Example 5), and seeded synthesis (Example 14).

Example 3: Solid-State ¹³ C MAS NMR of ZIF-7 and EMM-19

[00110] Figure 5 provides a comparison of the activated EMM-19 product of Example 2 and activated ZIF-7, as measured by 125-MI Iz ^L, C magic-angle spinning (MAS) NMR. in Figure 5, the spectrum for ZIF-7 is shown on the bottom, the spectrum for EMM- 19 is shown in the middle, and zoomed superimposed spectra are shown on the top. Asterisks in Figure 5 are believed to primarily indicate spinning sidebands.

[001111 Figure 5 shows distinct peaks corresponding to 5-azabenzimidazolate and benzimidazolate linkers, respectively, which are believed to support the conclusion that the organic linker content of E M-19 was indeed substantially 5-azabenzimidazolate, thereby indicating an empirical formula of Zn(5-azabenzimidazolate) ₂ for EMM- 19.

Example 4: Preparation and activation of ZIF-22

[00112] To a solution of -232 mg Ζη(Ν0 ) ₂ ·4Η ₂ θ and ~2 g 5-azabenzimidazole in ~20 mL DMF in a glass vial was added -244 triethylamine by using a micro- pipcttc. After the resulting mixture was substantially homogenized by sonication, it was transferred to a PTFE cup of a ~-45-mL Parr bomb. The Parr bomb was then seated and heated in an isothermal oven at -~140°C for about 24 hours. After reaction, the Parr bomb was removed from the oven and allowed to cool naturally to ambient temperature (about 25°C). Then, the Parr bomb was opened, the mother liquor decanted, and the solid product washed thoroughly with DMF (-5 mL x 3), stored in DMF, and labelled "as-synthesized ZIF-22 ^" . The purity of the product was confirmed by the excellent agreement of the powder X-ray diffraction pattern of as-synthesized ZIF-22 and the calculated pattern based on the crystal structure of ZIF-22 determined by single-crystal X-ray crystallography (Fig. 6).

[00113] An attempt to exchange the DMF solvent molecules occluded in as- synthesized ZIF-22 with acetonitrile, by using the procedure established for EMM- 19 and ZIF-7 (Example 2), proved unsuccessful. This was evidenced by the compromised powder X-ray diffraction pattern of acetonitrile-exchanged ZIF-22 (Fig. 6).

[00114] Instead, the as-synthesized ZIF-22 was activated according to a procedure disclosed in the article "insight into the crystal synthesis, activation and application of ZIF-20", RSC Advances, Vol. 1 , 201 1 , pp. 917-22 by Seoane et al (ZIF-20 is the purine counterpart of ZIF-22). Specifically, ( 1 ) a sample of about 1 10 mg as-synthesized ZIF- 22 was dried on a vacuum line (ultimate vacuum of about 20 mTorr) at ~70°C for about 6 hours to remove the DMF at the external surface of the sample and possibly the loosely occluded DMF inside the pores; (2) the dried sample was transferred to a glass vial, thoroughly washed with chloroform (-15 mL ^χ 3), and then continuously stirred in -15 mL chloroform by using a magnetic stirrer at ambient temperature (about 25°C) for about 30 hours; (3) the chloroform-exchanged sample was evacuated on a vacuum line (ultimate vacuum of about 20 mTorr) at ~70°C for about 10 hours to yield

"activated ZIF-22". The activated Z1F-22 sample prepared through chloroform- exchange had retained the original crystalline framework structure (Fig. 5).

Example 5: Comparison of adsorption/desorption properties of EMM-19, ZIF-7, and ZIF-22

[00115] C0 ₂ and N ₂ adsorption/desorption isotherms were measured at ~28°C for the activated EMM-19 of Example 2, the activated ZIF-22 of Example 4, and an activated ZlF-7, with two separate C0 ₂ isotherm experiments, starting at two different pressure points, being conducted for the EMM- 19 sample.

[00116] Figure 7 compares the C0 ₂ isotherms for EMM- 19, ZIF-7, and ZIF-22, and the N ₂ isotherms for EMM-19 and ZlF-7, with solid symbols being used for the adsorption branches and open symbols for the desorption branches. Figure 7 seems to show that EMM-19 sorbed more C0 ₂ at a lower C0 ₂ partial pressures, compared to that observed for ZIF-7. In addition. Figure 7 seems to show that the isotherm of ZIF-22 did not exhibit step-shaped hysteresis and that ZIF-22 exhibited far lower adsorption capacities at -760 Torr (-1 .1 mmol/g) and -76 Torr (-0.18 mmol/g) C0 ₂ partial pressures, as compared to the EMM-19 samples, over the measured pressure range.

[00117 J Figure 7 also seems to show, based on the C0 ₂ isotherms of EMM- 19 and ZIF-7, that both materials exhibited a step-shaped hysteresis and exhibited a CO? adsorption capacity of about 2.0-2.2 mmol/g at about 760 Torr (i. e. , in the near-plateau region after the step on the adsorption branch), but differed significantly in the onset point of the step, with the uptake threshold C0 ₂ partial pressure having shifted to a much lower pressure for EMM- 19 (about 400 Torr for ZIF-7, less than about 50 Torr for EMM- 19). Consequently, EMM- 19 appeared to adsorb more C0 ₂ than ZIF-7 in the relatively low C0 ₂ partial pressure region.

[00118] Without being bound by theory, the enhanced C0 ₂ adsorption at lower partial pressures observed for EMM- 19 was believed to indicate the suitability of the material for separating C0 ₂ from lower-pressure gas streams, for example, carbon capture for flue gas streams, in which a major challenge can be to separate CO? (minor component) from N ₂ (major component).

[001 19] Even though process schemes can be designed to operate at low ratios of adsorption loading (in mmol/g) for the minor component (in this case, CO?) vs. the adsorption loading (in mmol/g) for the major component (in this case, N ₂ ), it can be preferred in some embodiments for an adsorptive loading ratio for C0 ₂ over N ₂ for the ZIF material be at least 5, e.g. , at least 10, at least 15, at least 20, at least 25, at least 30, at least 35, at least 40, at least 45, or at least 50. Since the required equipment size, cost, and operating expenses can tend to be significantly lowered at higher adsorptive loading ratios, the separations processes can become much more attractive by utilizing materials and conditions that lead to higher adsorptive loading ratios. The adsorptive loading ratio is a property for a specific adsorbate-adsorbent pair, at given conditions of pressure and temperature ("standard" conditions of pressure and temperature can be measured at either operating partial pressures for the specific components and operating temperature conditions for the feedstream contacting the ZIF-containing adsorbent, or alternately at single component testing conditions, such as about 301 (about 28°C) and about 106.6 kPaa (about 800 Torr)). Other details of adsorptive loading ratios of C0 ₂ over N ₂ for ZIF materials, and their context in commercial separations processes, can be found, e.g. , in U.S. Patent Application Publication No. 2009/0214407.

Examples 6- 1 : Other Linker Exchange Reactions in DMF

[00120] A series of further linker exchange reactions using DMF as the solvent for different ZIF starting materials (in this case, ZIF-8 and ZIF-7) and different imidazole starting materials (in this case, 5-azabenzimidazole, 4-azabenzimidazole, and purine) were conducted as Examples 6- 1 1. The results are summarized in Table 1 below.

Example 6: Exchange of ZIF-8 with 4-Azabenzimidazole

[00121] A clear solution of -500 mg 4-azabenzimidazole in -5 mL DMF was prepared in a glass vial, and then added to -50 mg of solid ZIF-8, wfiich was previously weighed out in a PTFE cup of a ~45-mL Parr bomb. The Parr bomb was then sealed and heated in an isothermal oven at ~140°C for about 24 hours. After reaction, the Parr bomb was removed from the oven and allowed to cool naturally to ambient temperature (about 25°C). Then, the Parr bomb was opened, the mother liquor decanted, and the soiid product washed thoroughly with DMF (-5 mL ^χ 3 ) and stored in DMF.

[00122] As indicated by the powder X-ray diffraction patterns shown in Figure 8, the product appeared to comprise a mixure of ZIF-23 (DIA) with a small amount of unreacted ZlF-8 (SOD).

Example 7: Exchange of ZIF-8 with 5-AzabenzimidazoIe

[00123] A clear solution of -200 mg 5-azabenzimidazole in—15 mL DMF was prepared in a glass vial, and then added to ~50 mg of solid ZIF-8, which was previously weighed out in a PTFE cup of a ~45-mL Parr bomb. The Parr bomb was then sealed and heated in an isothermal oven at ~140°C for about 24 hours. After reaction, the Pan- bomb w ^r as removed from the oven and allowed to cool naturally to ambient temperature (about 25°C). Then, the Parr bomb was opened, the mother liquor decanted, and the solid product washed thoroughly with DMF (~5 mL 3) and stored in DMF.

[00124] As indicated by the powder X-ray diffraction patterns shown in Figure 9, the product appeared to comprise a mixure of HMM- 19 (SOD) and unreacted ZIF-8 (SOD).

Example 8: Exchange of ZIF-8 with 4-Azabcnzimidazolc

[00125] A clear solution of -200 mg 4-azabenzimidazole in -15 mL DMF was prepared in a glass vial, and then added to ~50 mg of solid ZIF-8, which was previously weighed out in a PTFE cup of a -45-mL Parr bomb. The Parr bomb was then sealed and heated in an isothermal oven at ~140°C for about 24 hours. After reaction, the Parr bomb was removed from the oven and allowed to cool naturally to ambient temperature (about 25°C). Then, the Parr bomb was opened, the mother liquor decanted, and the solid product washed thoroughly with DMF (~5 mL ^χ 3 ) and stored in DMF.

[00126] As indicated by the powder X-ray diffraction patterns shown in Figure 10, the product appeared to be unreacted ZIF-8 (SOD). Examplc 9: Exchange of ZIF-8 with Purine

[001 7] A clear solution of -200 mg purine in -15 mL DMF was prepared in a glass vial, and then added to -50 mg of solid ZIF-8, which was previously weighed out in a PTFE cup of a -23 -mL Parr bomb. The Parr bomb was then sealed and heated in an isothermal oven at ~140°C for about 24 hours. After reaction, the Parr bomb was removed from the oven and allowed to cool naturally to ambient temperature (about 25°C). Then, the Parr bomb was opened, the mother liquor decanted, and the solid product washed thoroughly with DMF (-5 mL χ 3) and stored in DMF.

[00128| As indicated by the powder X-ray diffraction patterns shown in Figure 1 1 , the product appeared to comprise a mixure of unreacted ZiF-8 (SOD) with an unidentified crystalline phase. The diffraction peaks corresponding to the unidentified phase (with asterisk marks) all appeared at two-thcta angles greater than about 13°, which can typically indicate a small unit cell, and thus are likely believed to indicate the presence of a dcnse/non-porous phase.

Example 10: Exchange of ZIF-7 with 5-Azabcnzimidazole

[00129| A clear solution of -1 g 5-azabenzimidazolc in -10 mL DMF was prepared in a glass vial, and then added to -100 mg of solid activated ZIF-7, which was previously weighed out in a PTFE cup of a ~45-mL Parr bomb. The Parr bomb was then sealed and heated in an isothermal oven at ~140°C for about 72 hours. After reaction, the Parr bomb was removed from the oven and allowed to cool naturally to ambient temperature (about 25°C). Then, the Parr bomb was opened, the mother liquor decanted, and the solid product washed thoroughly with DMF (-5 mL ^χ 3) and stored in DMF.

[00130] As shown in Figure 12, the powder X-ray diffraction pattern of the as- synthcsized product appeared identical to that of ZIF-7 (SOD). As shown in Figure 13, the solid-state ^{l j} C NMR data of the activated product appeared to confirm that the product was unreacted ZIF-7.

Example 11 : Exchange of ZIF-7 with Purine

[00131 ] A clear solution o -646 mg purine in -6.5 mL DMF was prepared in a glass vial, and then added to -65 mg of solid activated ZIF-7, which was previously weighcd out in a PTFE cup of a ~45-mL Parr bomb. The Parr bomb was then sealed and heated in an isothermal oven at ~ 140°C for about 72 hours. After reaction, the Parr bomb was removed from the oven and allowed to cool naturally to ambient temperature (about 25°C). Then, the Parr bomb was opened, the mother liquor decanted, and the solid product washed thoroughly with DMF (~5 n L ^x 3) and stored in DMF.

[00132] As shown in Figure 14, the powder X-ray diffraction pattern of the product closely resembled that of ZIF-23 (D1A).

|00133] As shown in Figure 15, the powder X-ray diffraction pattern of the product was indexed by using Materials Data JADE 9 software to an orthorhombic unit cell, space group P2{l{l a ~ 9.358 A, b ~ 1 0.154 A, c ~ 12.434 Α, α ~β ~ γ ~ 90°, which was very close to that of ZIF-23 (orthorhombic, P2 {1{1 _\ , a ~ 9.5477 A, b ~ 10.1461 A, c ~ 12.4459 A. α ~β ~ γ ~ 90°) reported in the Supplementary Information for "Zeolite A Imidazolate Frameworks", Nature Materials, Vol. 6, 2007. pp. 501 -6 by Yaghi and co-workers. Without being bound by theory, it is believed that the product comprised the purine counterpart of ZIF-23, i. e. , a Zn(purinate) ₂ of the framework type DIA.

Table 1.

5-Aza - 5-azabenzi m idazole; 4-Aza - 4-azabenzimidazole

Example 12: Linker Exchange reactions for ZIF-8 in acctonitrile

[00134] A series of three separate exchange reactions for ZIF-8 using acctonitrile as the solvent for different imidazole starting materials (in this case, 5-azabenzimidazolc, 4-azabenzimidazole, and purine) were conducted as described below ^' . The results are summarized in fable 2 below.

[00135] A solid mixture o -50 mg ZIF-8 and -200 mg 5-azabenzimidazole was placed in a ~20-mL glass vial. About 15 ml. acetonitrile was added into the vial, and the mixture was homogenized by sonication. The vial was then capped and labeled as Reaction 1. The procedure described above was repeated twice, using respectively 4- azabenzimidazolc (Reaction 2) and purine (Reaction 3), instead of 5-azabenzimidazoIe.

[00136] These three capped vials were placed in a ~300-mL autoclave. A small amount of acetonitrile was added into the autoclave to balance the acetonitrile vapor pressure inside the vials. The autoclave was then sealed and heated at ~140°C for -48 hours (~2°C/min ramp rate). After the autoclave had cooled naturally to ambient temperature (about 25°C), the three reaction vials were retrieved from it. For each vial, the mother liquor was decanted, and the solid product was washed thoroughly with acetonitrile (~5 ml. ^χ 3) and stored in acetonitrile.

[00137] As indicated by the powder X-ray diffraction patterns shown in Figure 16, the product of Reaction 1 was believed to comprise unreacted ZIF-8 (SOD).

[00138] As indicated by the powder X-ray diffraction patterns shown in Figure 17, the product of Reaction 2 was believed to comprise ZIF-23 (DIA).

[00139] As indicated by the powder X-ray diffraction patterns shown in Figure 18, the product of Reaction 3 appeared to be the same as that of Example 1 1 , i. e. , a Zn(purinate): of the framework type DIA.

Table 2.

5-Aza ^~ 5-azabenzimidazole: 4-Aza = 4-azabenzimidazole

Example 13: Solvothermal synthesis in DMF using ZnO as the zinc source

[00140] A clear solution of -500 mg 5-azabenzimidazole in -5 niL DMF was prepared in a glass vial, and then added to ~1 8 mg of solid ZnO, which was previously weighed out in a PTFE cup of a -45-mL Parr bomb. The Parr bomb was then sealed and heated in an isothermal oven at ~140°C for about 24 hours. After reaction, the Parr bomb was removed from the oven and allowed to cool naturally to ambient temperature (about 25°C). Then, the Parr bomb was opened, the mother liquor decanted, and the solid product washed thoroughly with DMF (~5 mL ^χ 3) and stored in DMF. [00141 ] As indicated by the powder X-ray diffraction patterns shown in Figure 19, the product appeared to comprise a mixure of EMM- 19 (SOD) and unreacted ZnO.

[00142] A comparison of the results of Example 13 with those of Example 2 are shown in Table 3 below.

Table 3.

5-Aza - 5-azabenzimidazole

Example 14: Solvothermal synthesis in DMF seeded with EMM-19

[00143] A solution of -1 g 5-azabenzimidazole and ~1 16 mg Zn(N0 ₃ ) ₂ *4H ₂ 0 in -1 0 mL DMF was prepared in a glass vial, and then added to ~5 mg of solid activated EMM- 19 (prepared according to Example 2), which was previously weighed out in a P ΠΈ cup of a ~23-mL Parr bomb. The Parr bomb was then sealed and heated in an isothermal oven at ~ 140°C for about 24 hours. After reaction, the Parr bomb was removed from the oven and allowed to cool naturally to ambient temperature (about 25°C). Then, the Parr bomb was opened, the mother liquor decanted, and the solid product washed thoroughly with DMF (~5 mL ^x 3) and stored in DMF.

[00144] As indicated by the powder X-ray diffraction patterns shown in Figure 20, the product appeared to comprise a mixure of ZIF-22 (LTA) and EMM- 19 (SOD), which appeared to indicate the relative ineffectiveness of seeding in inhibiting the formation of the commonly observed LTA phase, thus appearing to confirm a lack of fundamental change in the crystallization mechanism of the system.

[00145] A comparison of the results of Example 14 with those of Example 2 are shown in ^' fable 4 below. Tablc 4.

5-Aza - 5-azabenzimidazole

Example 15: Synthesis of ZIF-7 in solvent mixture of MeCN and TEA

[00146] Λ mixture of -4.8 g (~40 mmol) benzimidazole and -5.33 g (-20 mmol) Zn(N( 3) ₂ 4H ₂ 0 in -240 mL acetonitrile was prepared in a vessel and sonicated for about 20 minutes. Then -5.66 mL (-40 mmol) of tricthylamine (as an example of a Bronstcd base) was added and the corresponding mixture then sonicated for an additional -40 minutes. The solution was then sealed in a Parr acid digestion bomb and heated in an isothermal oven at -100°C for about 48 hours. After reaction, the Parr bomb was removed from the oven and allowed to cool naturally to ambient temperature (about 25°C). Then, the Parr bomb was opened, the mother liquor decanted, and the solid product washed thoroughly with acetonitrile (-90 mL χ 3 ) and stored in acetonitrile. Powder x-ray diffraction (not shown) of a dried slurry of the product indicated it was indeed ZIF-7. Further measurements indicated that the product (sample was outgassed for -3 hours at about 75°C) also had a BET surface area of - 12.7 m ² /g. A COi adsorption isotherm was also done on the product (also not shown), yielding relatively similar adsorption, desorption, and hysteresis behavior as a ZIF-7 product synthesized in DMF. These testing results appear to indicate that ZIF-7, or more generally potentially all ZIFs and MOFs (or some subset of ZIFs and MOFs). can be synthesized using solvents (or solvent mixtures) that have a relatively low boiling point and/or a relatively high vapor pressure, e.g. , higher than DMF, and perhaps higher than water.

[00147] The significance of being able to use relatively low boiling point and/or a relatively high vapor pressure solvents/solvent mixtures as synthesis media is tied to the difficulty of removing detectable traces of higher boiling point and/or lower vapor pressure solvents, even under relatively severe and repeated solvent removal/exchange conditions. For instance, in the case of ZlF-8 made by a conventional synthesis in DMF and stored in DMF, experiments were undertaken to determine the severity of the treatment necessary to remove all traces of DMF from the ZIF-8 sample. ^Ij C solid state MAS Bloch decay NM w ^; as used to detect trace amounts of DMF in each sample. A single solvent exchange with acetonitrile (desolvated of DMF at ambient temperature at a reduced pressure of no more than about 20 mTorr, then washed with excess MeCN, and desolvated again at ambient temperature at a reduced pressure of no more than about 20 mTorr) was ineffective at removing DMF - indeed, considerable DMF was still found to be detectable by NMR techniques. DMF was also still detectable upon drying a Z1F-8/DMF sample at a temperature of about 100°C under a reduced pressure of no more than about 1 0 mTorr for about 2 hours, and even upon drying a ZIF-8/DMF sample at a temperature of about 250°C (almost 100°C higher than its atmospheric boiling point!) under a reduced pressure of no more than about 10 mTorr for about 2 hours. Only when a Z1F-8/DMF sample was dried at a temperature of about 250°C under a reduced pressure of no more than about 10 mTorr overnight (for about 16 hours) were there no detectable traces of DMF, as measured by ^L 'C NMR techniques. As this exemplary case shows, considerable money, effort, time, and resources could be saved if such synthesis reactions were able to be conducted in solvents (or solvent mixtures) having relatively low boiling points and/or relatively high vapor pressures.

[00148] While the present invention has been described and illustrated by reference to particular embodiments, those of ordinary skill in the art will appreciate that the invention lends itself to variations not necessarily illustrated herein. For this reason, then, reference should be made solely to the appended claims for purposes of determining the true scope of the present invention.